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Resumo
A evoluc¸a˜o das tecnologias de processamento de dados tem permitido avanc¸os significativos na a´rea
das cieˆncias da vida. As melhorias na quantidade e na qualidade dos dados disponı´veis para ana´lises
biolo´gicas teˆm proporcionado o estudo em larga escala de diversos processos biolo´gicos.
O splicing alternativo e´ um mecanismo molecular que contribui significativamente para a criac¸a˜o de
proteı´nas com func¸o˜es distintas a partir do mesmo gene. Encontrando-se este processo envolvido no
controlo de muitos mecanismos celulares, a sua desregulac¸a˜o pode promover a progressa˜o de um vasto
leque de doenc¸as. Por exemplo, existem associac¸o˜es descritas entre alterac¸o˜es de splicing alternativo e
a maioria das caracterı´sticas de cancro (como evasa˜o ao sistema imunita´rio e crescimento celular auto-
sustentado). Estas associac¸o˜es podem ser analisadas atrave´s de dados disponı´veis online, como a partir
dos dados do The Cancer Genome Atlas (TCGA) que incluem dados clı´nicos e do perfil molecular de
pacientes humanos com diversos tipos de tumores.
A ana´lise e interpretac¸a˜o correcta dos resultados requer competeˆncias multi-disciplinares em biolo-
gia, estatı´stica e informa´tica. Como nem todos os cientistas das cieˆncias da vida se sentem conforta´veis a
utilizar ferramentas com uma interface baseada em linha de comandos, va´rios programas com uma inter-
face gra´fica teˆm emergido para auxiliar na quantificac¸a˜o, ana´lise e visualizac¸a˜o de dados biolo´gicos. As
ana´lises tambe´m podem ser facilitadas atrave´s da utilizac¸a˜o de dados previamente processados que esta˜o
disponı´veis publicamente para casos comuns de utilizac¸a˜o, evitando-se o processamento dispendioso de
dados a nı´vel de tempo e aliviando tambe´m a carga na largura de banda relativamente a` transfereˆncia de
dados brutos.
Infelizmente, as ferramentas existentes para a ana´lise de splicing alternativo focam-se primariamente
na sua quantificac¸a˜o ou apresentam funcionalidades limitadas para a ana´lise subsequente dos eventos
de splicing alternativo. Ale´m disso, muitos programas que quantificam o splicing alternativo utilizam
dados brutos e na˜o tiram partido dos dados processados disponı´veis de fontes pu´blicas como os dados
do TCGA. Assim sendo, existe a necessidade de criar um programa interactivo e fa´cil de usar que se
dedique a` ana´lise subsequente dos dados para auxiliar tanto na explorac¸a˜o como no estudo diferencial de
dados do splicing alternativo, permitindo assim a potencial descric¸a˜o de novos mecanismos envolvidos na
progressa˜o de doenc¸as. Ademais, a integrac¸a˜o da informac¸a˜o clı´nica associada (ausente na maioria dos
programas disponı´veis) podera´ ajudar na identificac¸a˜o de factores de progno´stico e de alvos terapeˆuticos.
Todos os membros do laborato´rio de Biologia Computacional do Instituto de Medicina Molecular
(Faculdade de Medicina da Universidade de Lisboa) sa˜o partes interessadas (stakeholders) no projecto,
ja´ que apoiam o desenvolvimento do programa e sera˜o utilizadores finais deste. O grupo efectua diari-
amente muitas das ana´lises e visualizac¸o˜es incorporadas no projecto, tendo ajudado no seu desenvolvi-
mento ao examinar os detalhes de cada ana´lise.
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Para o desenvolvimento de uma ferramenta u´til, os requisitos necessa´rios foram comunicados pelas
partes interessadas ao longo de va´rias reunio˜es. Acordou-se que a aplicac¸a˜o se deve focar em obter
dados a partir de fontes online (como do TCGA), processar, carregar e manipular os dados na aplicac¸a˜o,
quantificar splicing alternativo e analisar estatisticamente os dados disponı´veis (por exemplo, ana´lise de
sobreviveˆncia, componentes principais e diferencial de splicing), incluindo funcionalidades para criar e
editar grupos baseados nos dados clı´nicos e para gravar os resultados obtidos (conforme apropriado).
Outras caracterı´sticas de interesse incluem a capacidade de adicionar novos reposito´rios, reconhecer
novos formatos aquando da identificac¸a˜o e do carregamento de ficheiros, acrescentar novas ferramentas
para manipulac¸a˜o de dados e incorporar novas ana´lises e visualizac¸o˜es a partir dos dados carregados.
Consoante os requisitos funcionais discutidos, os atributos na˜o funcionais incluem a capacidade de
modificac¸a˜o (fa´cil de modificar e introduzir novas componentes de sistema), a usabilidade (interface
fa´cil de usar e consistente que mostre mensagens de erro e de aviso informativas), o desempenho (foco
no tempo tomado pelas operac¸o˜es dado a quantidade de dados para processar e analisar) e a capacidade
de reposta (informar o utilizador da operac¸a˜o a decorrer atrave´s de uma barra de progresso e bloqueando
o bota˜o de inı´cio de uma acc¸a˜o durante a operac¸a˜o).
Dada a importaˆncia da ana´lise estatı´stica e biolo´gica no projecto e do interesse da comunidade ci-
entı´fica no R e no Bioconductor (reposito´rio de pacotes R associados a dados biolo´gicos), foi deci-
dido que o projecto seria desenvolvido com base no Shiny, uma framework para desenvolvimento de
aplicac¸o˜es web que permite construir aplicac¸o˜es interactivas com a linguagem R e incorporar gra´ficos
interactivos desenvolvidos em HTML5 e JavaScript. Todas as funcionalidades destas ferramentas foram
testadas e estudadas atrave´s de um proto´tipo antes da concepc¸a˜o da arquitectura.
A arquitectura do sistema foi desenhada de forma modular e extensı´vel, consoante os requisitos
mencionados, estimulando assim contribuic¸o˜es de quaisquer partes interessadas, bem como facilitando a
expansa˜o do seu suporte para outras fontes de dados, formatos de ficheiro e ana´lises e visualizac¸o˜es efec-
tuadas sem necessidade de alterar as funcionalidades ba´sicas. Para ale´m de facilitar testes e correcc¸o˜es
a`s unidades do programa, a expansibilidade possibilita actualizar as ferramentas com novos me´todos
explorados e desenvolvidos na a´rea e, consequentemente, aumentar o interesse da comunidade cientı´fica
no programa.
A modularidade foi implementada de forma a que, quando o utilizador chama a func¸a˜o para comec¸ar
a interface visual do programa, da´-se inı´cio a uma se´rie de chamadas hiera´rquicas a outras func¸o˜es do
programa, as quais preparam a interface e a lo´gica de todos os mo´dulos disponı´veis. O programa e´ com-
posto pelos mo´dulos de obtenc¸a˜o de dados (para obter dados locais ou do TCGA e processa´-los de acordo
com o seu formato), quantificac¸a˜o de splicing alternativo, ana´lise de dados (ana´lises clı´nica, componen-
tes principais e diferencial e informac¸o˜es associadas aos genes dos eventos de splicing), agrupamento
de dados e definic¸o˜es do programa. Os gra´ficos interactivos foram adaptados ao diferentes mo´dulos
conforme apropriado, recorrendo ao pacote Highcharter.
A aplicac¸a˜o realiza va´rios testes automa´ticos para validar o output das unidades do programa, de
forma a alertar o programador caso haja alguma mudanc¸a que altere o output esperado. Esta funcionali-
dade esta´ incorporada em ferramentas de testes contı´nuos como o Travis-CI e o AppVeyor. A cobertura
do co´digo testado tambe´m e´ avaliada pela ferramenta CodeCov.
Para testar a interface do programa, foram realizados testes de usabilidade a 6 membros do grupo
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de Biologia Computacional do Instituto de Medicina Molecular no seu ambiente de trabalho, consoante
diversas tarefas pre´-definidas. Os participantes escolhidos representam a pu´blico-alvo: utilizadores pro-
ficientes no conhecimento do domı´nio de interesse. Va´rias me´tricas foram medidas durante as sesso˜es
de teste, incluindo o nu´mero de problemas encontrados e as opinio˜es dos utilizadores sobre cada tarefa.
Cada participante utilizou uma versa˜o que tentou melhorar alguns dos problemas encontrados pelo par-
ticipante anterior. A interface foi considerada, em me´dia, muito boa ou excelente para cada tarefa e
permitiu atentar a 45 problemas distintos (actualmente, pelo menos 25 desses problemas ja´ foram resol-
vidos). Para melhorar a usabilidade e funcionalidade do programa, solicita´mos recentemente o parecer
de contribuidores externos especializados na ana´lise de splicing alternativo.
A aplicac¸a˜o tambe´m foi testada a nı´vel de desempenho para va´rios tipos de tumores. Uma ana´lise
completa para dados associados a pacientes com cancro da mama (cerca de 1097 pacientes, o maior
nu´mero de pacientes disponı´veis para qualquer tipo de tumor no TCGA) demora cerca de 6 minutos
atrave´s da interface visual: 47 segundos para carregar os dados necessa´rios do TCGA (excluindo tempo
de transfereˆncia), 2 minutos e 39 segundos para quantificar o splicing alternativo e 2 minutos e 35 segun-
dos para a ana´lise diferencial baseada nas amostras normais versus tumorais. A interface visual adiciona
um overhead ao desempenho, daı´ ter sido escolhida para medir os tempos nos piores casos possı´veis.
Em suma, temos estado a desenvolver uma aplicac¸a˜o web em R com uma interface gra´fica para a
quantificac¸a˜o, ana´lise integrada e visualizac¸a˜o de dados de splicing alternativo a partir de grandes con-
juntos de dados transcripto´micos provenientes do projecto The Cancer Genome Atlas (TCGA). Esta
ferramenta interactiva realiza ana´lise de componentes principais e outras ana´lises explorato´rias grafi-
camente assistidas. Entre os seus aspectos mais inovadores encontra-se a ana´lise de variaˆncia (que a
pesquisa do grupo revela como importante na detecc¸a˜o de alvos de interesse de outra forma despercebi-
dos) e a incorporac¸a˜o de dados clı´nicos (como esta´dio tumoral e dados de sobreviveˆncia) associados com
as amostras do TCGA. De interesse tambe´m se encontra incorporado o acesso visual interactivo para ma-
peamento geno´mico e anotac¸a˜o funcional dos eventos de splicing alternativo seleccionados. Aplicac¸a˜o
desenvolvida permitiu revelar assinaturas de splicing alternativo especı´ficos de cancro e novos factores
putativos de progno´stico.
O co´digo da ferramenta ja´ se encontra gratuitamente disponı´vel atrave´s de uma licenc¸a MIT no
GitHub (http://github.com/nuno-agostinho/psichomics) e foi enviada para ser aceite
no Bioconductor. Actualmente, a aplicac¸a˜o apenas pode ser utilizada localmente, mas ha´ planos para a
disponibilizar num servidor web do Instituto de Medicina Molecular.
Palavras-chave: Bioinforma´tica, cancro, splicing alternativo, visualizac¸a˜o
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Abstract
Alternative splicing (AS) allows proteins with distinct functions to be generated from the same gene,
being involved in the control of many common cellular processes. Its deregulation may therefore foster
the progression of a wide range of diseases. For instance, associations between most of the hallmarks of
cancer and AS alterations have been reported.
The advent of next-generation sequencing has allowed the profiling of transcriptomes beyond gene
expression, enabling genome-wide studies of AS. However, the currently available tools for the analysis
of AS from RNA-Seq data are not user-friendly and primarily focus on quantification, having limited
features for downstream analysis.
To overcome these limitations, we have been developing an R application with a graphical inter-
face for the integrated analysis of AS from large transcriptomic datasets, namely from The Cancer
Genome Atlas (TCGA) project. The tool interactively performs clustering, principal component and
other graphically-assisted exploratory analyses. Amongst its innovative aspects are the analysis of vari-
ance (which our research shows to be important in the detection of otherwise unnoticed putative targets)
and the direct incorporation of clinical features (such as tumour stage or survival) associated with TCGA
samples. Interactive visual access to genomic mapping and functional annotation of selected AS events
is also incorporated. We have successfully used the application in the revelation of cancer-specific AS
signatures and associated novel putative prognostic factors.
The application’s architecture is modular and extensible, aiming to stimulate contributions from its
users, as well as to gradually expand its support to other data sources and file formats and the scope of its
analysis and visualisation tools without modifying its core functionalities. The tool is available in GitHub
(http://github.com/nuno-agostinho/psichomics) and was submitted to be accepted in
Bioconductor. Currently, the application is locally run but there are plans to deploy it in a web server
from Instituto de Medicina Molecular.
Keywords: Bioinformatics, cancer, alternative splicing, analysis, visualisation
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Chapter 1
Introduction
The fast development of data processing technologies has had a large impact on life sciences research.
The ever-increasing amount and resolution of available data for biological analyses has recently allowed
the study of a vast variety of biological processes in a large scale [1].
One of the molecular mechanisms that most significantly contributes to protein diversity is alternative
splicing [2,3]. Given the regulatory roles of this process in cellular metabolism, its deregulation is linked
with disease development, including cancer [4–8] and neurodegeneration [8, 9]. This association can be
analysed by retrieving biological data from online sources, such as The Cancer Genome Atlas (TCGA),
a project that catalogues clinical and molecular profiling data of different kind of human tumours [10].
However, correct analyses and interpretation of results require a multi-disciplinary expertise in bi-
ology, statistics and computer science. As not every life scientist is comfortable using tools based on
a Command-Line Interface (CLI), many programs with a visual interface have emerged to assist in the
quantification, analysis and visualisation of biological data [11–13]. Processed data is also publicly of-
fered for the most common research uses to facilitate data analyses, overcoming the time-consuming step
of data processing and bandwidth concerns related with raw data transference.
Unfortunately, current tools used for studying alternative splicing either present over-simplistic anal-
yses or focus mostly on its quantification [9, 14–16]. Furthermore, many of the programs that quantify
alternative splicing use raw data without leveraging the available higher-level data from sources such as
TCGA [9, 14, 15].
Therefore, there is a need for an user-friendly and interactive program that goes beyond quantification-
only analysis to assist in both exploration and differential study of alternative splicing data, thus allowing
the potential characterisation of novel mechanisms involved in disease progression. Moreover, the inte-
gration of clinical-related information (which is absent in most available programs) may help in identi-
fying relevant prognostic factors and therapeutic targets.
To overcome these limitations, we have been developing a web application called PSIchomics to
quantify, analyse and visualise alternative splicing data. This app is an R package with a modular design
to easily introduce new features, including the support of new file formats and new data analyses. The
app is currently available in GitHub at http://github.com/nuno-agostinho/psichomics
and it will be released in Bioconductor, a repository of R packages for biological data [17].
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1.1 Requirements
All the members of the Computational Biology laboratory at Instituto de Medicina Molecular (Fac-
uldade de Medicina, Universidade de Lisboa) are stakeholders in the project since they have an interest
in the program development and they are part of the end-users. They also perform many of the analyses
and visualisations of this project daily and aided in the program development by scrutinising the details
of each analysis.
The requirements of the project were stated in natural language by the stakeholders through recurrent
discussions to minimise any missteps. My background in biology helped in understanding the functional
requirements and how to develop the application. Expectedly, not all requirements were stated in the first
meetings and some of the requirements evolved with time, reinforcing the need for successive conversa-
tions with the stakeholders.
The following was agreed upon: the application must allow data retrieval from online sources (such
as retrieval of TCGA data), alternative splicing quantification and statistical data analyses (including sur-
vival, principal component and differential splicing analyses) with interactive plots, as appropriate. The
diverse analyses also must support the creation and manipulation of data grouping. Also of interest, the
program must have an easy-to-use interface and to easily allow to add new data sources, recognise new
file formats when loading data, add new manipulation tools and incorporate new analyses and visualisa-
tions.
There were no additional constraints, which allowed to freely choose the programming language and
the type of program (whether a desktop or web application, a library, etc).
1.2 Contributions
The design, implementation, testing and deployment of the application were conducted by me with
suggestions and guidance from my laboratory colleagues and advisors. The duration of the project
activities is plotted in figure 1.1.
All the members of the Computational Biology laboratory at Instituto de Medicina Molecular (Fac-
uldade de Medicina da Universidade de Lisboa) are stakeholders in the project since they are part of the
future end-users. They also assisted program development, namely the fine details of each data analysis
step, given that they commonly perform the type of analyses and visualisations this project focuses on.
Additionally, they participated in the usability tests of the program.
Prof. Dr. Anto´nia Lopes (Faculdade de Cieˆncias da Universidade de Lisboa) also made valuable
suggestions to the architecture of the application.
During the application development, I have also contributed to some open-source projects, such as
the R package Highcharter with the code of some graphical plots (survival curves, density plots and
smaller additions) that are already part of the latest package release [18]. I have also contributed to Shiny
with code for a text area input [19]. Additionally, I suggested improving code reusability to promote
information hiding in Firebrowser, an R package that works as a client to the Firehose Application
Program Interface (API) and provides both the data available in TCGA and diverse analyses on TCGA
datasets [20]. The authors of Firebrowser kindly offered me co-authorship of their manuscript titled
Firebrowser: An R Client to the Broad Institute’s Firehose Pipeline for my participation in the project.
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Figure 1.1: Gantt chart with the duration of the project’s activities. The project started in September
2015 and ended in September 2016.
The final manuscript, which I also reviewed, was submitted to Database: The Journal of Biological
Databases and Curation and it is currently under review.
Other notable contributions I made include cross-referencing alternative splicing events from four
programs that quantify alternative splicing events (MISO [14], VAST-TOOLS [9], rMATS [15] and
SUPPA [16]). This is useful to the Computational Biology group in order to compare results between the
mentioned tools. Additionally, I performed the alternative splicing quantification of 116 rat RNA-Seq
samples [21] using SUPPA and rMATS for an ongoing research project on toxicotrancriptomics in the
lab.
Moreover, we will write a research article on the developed program, to be submitted to the Bioin-
formatics journal. This project was already presented in a poster session at the EMBO Young Scientists’
Forum 2016 (Lisbon, Portugal), a meeting for life scientists.
1.3 Workplace
All the work was developed at Instituto de Medicina Molecular (Faculdade de Medicina da Univer-
sidade de Lisboa) with the guidance of Dr. Nuno Morais (group leader of the Computational Biology
group) and Prof. Dr. Andre´ Falca˜o (supervisor from Faculdade de Cieˆncias da Universidade de Lisboa).
The Instituto de Medicina Molecular is a research entity focused on biomedical research and it offers
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diverse facilities to support the everyday work taking place in the institute, such as dedicated services to
microscopy imaging, information technology support and animal facilities1.
The stakeholders were always available for questions and suggestions which allowed the project to
progress nicely thanks to their constant feedback. There were also some focused meetings to discuss the
project more deeply, including a presentation of the project to other members of the Instituto de Medicina
Molecular, which allowed me to get input on the project from third-parties that knew little or nothing at
all about the project.
1.4 Document Structure
The remaining sections of this document are organised as follows:
• Chapter 2 - ”Concepts and Related Work” explores the biological concepts and existing solutions
for the quantification and analyses of alternative splicing.
• Chapter 3 - ”Materials and Methods” shortly describes the approaches involved in the work per-
formed.
• Chapter 4 - ”Design Decisions” discusses the choice of the programming language, the develop-
ment of the prototype and the program’s architecture.
• Chapter 5 - ”Implementation” examines the current implementation of the program and its mod-
ules. Also, it features case studies related to the program’s functionality.
• Chapter 6 - ”Testing” details tests performed on the program, including installation, usability, unit
and continuous testing. It also features software benchmarking.
• Chapter 7 - ”Deployment” delves into software deployment and open-source licenses.
• Chapter 8 - ”Conclusions” states final remarks, the importance of this project and plans for future
work.
1More information at https://imm.medicina.ulisboa.pt (last accessed on 23 August 2016)
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Concepts and Related Work
2.1 Genetic Information Transfer
Cell functions are dependent on the information encoded in segments of deoxyribonucleic acid
(DNA) molecules called genes. Each gene is a segment of DNA that is copied to ribonucleic acid (RNA)
in a process referred to as transcription. After this process, messenger RNA (mRNA) molecules carry
the information as templates for proteins to be synthesised in a process called translation [22, 23].
Figure 2.1: pre-mRNA is synthesised from DNA in the cell nucleus
and then processed into a mature mRNA (or simply mRNA). Finally,
the mRNA is exported out of the nucleus to serve as the template of
a new protein.
The mRNA sequence involved
in protein synthesis is not identical
to its genes. For instance, the ends
of the mRNA sequence, known
as untranslated regions (UTRs),
operate on functions related to
the mRNA translation but they do
not serve as part of the protein-
coding template. mRNA pro-
cessing also includes a splicing
mechanism that removes some
segments (called introns) of the
primarily transcribed RNA (pre-
mRNA) and keeps its remaining
segments (exons) as part of the se-
quence that will encode for a protein (figure 2.1) [3, 23–25].
2.2 Alternative Splicing
The majority of human mRNAs undergo alternative splicing. In this process, the splicing of a single
pre-mRNA may occur differently by exon exclusion, exon truncation, intron retention or even a combi-
nation of the former that may result in a great diversity of mRNA variants (known as mRNA isoforms)
translatable into specific proteins (protein isoforms) [3, 24]. Even though they are encoded by the same
gene, protein isoforms may have different or even antagonising functions. One such example is the
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KLF6 gene whose protein isoforms are involved in tumour suppressor functions with the exception of
one splicing isoform that promotes tumour growth and dissemination [26].
Figure 2.2: Types of alternative splicing events. In the given cases, each gene may express one of the two
mRNA variants depicted on the right by inclusion and exclusion of specific exons. Constitutive exons
are depicted in blue while alternative ones are depicted in orange and green.
Alternative splicing is common in mammals and invertebrates and particularly abundant in primates.
The average human gene has 3,5 isoforms compared to 2,75 in mice, 1,25 in fruit flies and 1,25 in
nematodes, which supports an association between alternative splicing and organismal complexity [27,
28]. Interestingly, alternative splicing rates are also tissue-dependent in vertebrates. Alternative splicing
is much more frequent in the brain than in other tissues like the heart, liver and kidney [28].
Alternative splicing can occur in different ways which have been categorised in the following types:
skipped exon (SE), intron retention (IR), alternative 5’ (A5SS) and 3’ (A3SS) splice sites, alternative
first (AFE) and last (ALE) exon, mutually exclusive exons (MXE) and tandem 3’ UTR (depicted in
figure 2.2). Although this categorisation is widely used, it is criticised for its inflexibility regarding more
complex events [29].
2.2.1 Association with Disease
Alternative splicing is involved in the control of many cellular processes [4]. Expectedly, its dereg-
ulation is associated with a wide range of diseases, namely the progress of cancer [4–8] and neurode-
generative disorders [8, 9]. For instance, certain tumour cells inhibit programmed cell death (a defence
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mechanism against cancer cells) by skipping exons 3 to 6 in mRNAs from the caspase 9 gene [30].
Figure 2.3: Regulators in the hallmarks of cancer are alternatively spliced. The gene SRSF1 is an al-
ternatively spliced regulator that is reported to affect at least four cancer hallmarks. Image retrieved
from [4].
Specifically during tumour progression, normal cells may progressively acquire oncogenic properties
known as the hallmarks of cancer, including cell death evasion, tissue invasion and metastasis, limitless
replication, and immune system evasion, among others [4, 31]. These hallmarks have been associated
with a diversity of deregulated splicing isoforms [4] as depicted in figure 2.3. Studying this association
allows for a better understanding of tumour formation and progression, namely by identifying isoforms
involved in cancer development and if they can be potential therapeutic targets.
2.2.2 Quantification
Alternative splicing may be profiled by next-generation RNA sequencing (RNA-seq) [1].This tech-
nology yields short RNA sequence text strings (called reads) that are mapped to a DNA of reference [1]
(as depicted in figure 2.4) or to a transcriptome (i.e. the set of all RNAs1 in a cell type or organism) of
reference.
The presence of a given exon may be quantified using the percent spliced-in (PSI) metric, corre-
sponding to the proportion of isoforms that include a certain exon [2, 32, 33]. The distribution of PSI
values for each alternative splicing event can then be compared between different groups. For instance,
distributions with a statistical significance difference between normal and disease samples or between
tumour stages may reveal events related to disease progression.
1RNAs are also known as transcripts.
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Figure 2.4: RNA sequencing and read mapping. RNA is first extracted from a sample (1) and divided
into small fragments (2). Next, these fragments are converted to DNA (3). The DNA fragments are
then sequenced, producing short text strings called reads (4). Finally, these reads are mapped to a DNA
of reference (5), which allows to reconstruct the extracted mRNAs and identify exon coordinates in the
reference DNA.
Quantification Tools
There are several programs that quantify alternative splicing, including MISO [14], AltAnalyze [11],
VAST-TOOLS [9], rMATS [15], jSplice [35] and SUPPA [16]. Exon inclusion levels can be calculated
using junction reads alone (depicted in the bottom of figure 2.4), as in the case of VAST-TOOLS and
jSplice [9, 35], although MISO and rMATS were specifically designed to use additional exon-spanning
reads to obtain PSI values with greater precision [14, 15]. Exceptionally, the quantification of intron
retention events requires not only junction reads but also mid-intron and retention reads to distinguish
these events from other transcript variations (figure 2.5) [34].
The process to quantify alternative splicing events can take a long time if programs use complex and
accurate algorithms; for instance, MISO and rMATS use time-consuming Bayesian inference to properly
identify to which isoforms the sequencing reads belong to [14,15]. Conversely, programs like SUPPA and
jSplice rely on already processed data to estimate those same values, improving the speed of calculations
by orders of magnitude while retaining enough accuracy when compared to previous methods [16, 35].
Although the aforementioned tools quantify transcriptomic data, only AltAnalyze and jSplice accept
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Figure 2.5: Quantification of an intron retention
event requires junctions reads (illustrated as spliced
intron reads), mid-intron reads and retention (i.e.
exon-intron junction) reads. Image retrieved from
[34].
junction read counts as input to measure the levels of exon inclusion [11,35]. This allows these programs
to quantify data from available large-scale databases like TCGA — a human tumour data repository
that also includes matched normal samples2 in a smaller scale [10] — and Genotype-Tissue Expression
project (GTEx) — a database of multiple normal human tissue data [36]. Usage of both databases is
extensively reported in the literature [6, 7, 37, 38].
The quantification of alternative splicing events is followed by statistical analyses, including differ-
ential splicing analysis. Although some of the previously mentioned tools also perform downstream
analyses of alternative splicing, they mainly focus on its quantification.
2.3 Analytical Tools
There are many tools that analyse transcriptomic data. However, most do not focus on alternative
splicing [13,39,40]. The few programs that do, either present over-simplistic differential splicing analysis
or no proper downstream analysis to assist its biological interpretation. Some of the current tools for
splicing analysis include:
• TIN [41] is an R package to analyse alternative splicing data in cancer; yet, the package does not
have a graphical interface; also, instead of using data from RNA-seq, TIN bases the analyses on
micro-array3 data.
• VAST-TOOLS [9] is a command-line tool written in Perl and R that performs limited analyses and
inflexible (i.e. not explorable nor personalisable) visualisations from raw data.
• AltAnalyze [11] is a Java program with a graphical user interface that performs limited analyses
based on junction reads but its documentation lacks information on splicing quantification.
• SpliceSeq [42], a Java software that identifies alternative splicing patterns in RNA-seq data. A
particularly relevant approach is TCGA SpliceSeq [12], a web version of SpliceSeq for TCGA
data that can focus on a given gene of interest or on all genes with significant splicing variation
and show the respective exon inclusion levels for a given tumour type compared to normal tissue;
2Matched normal samples are retrieved from the same tissue where the tumour was found or from blood of the same patient.
3An older method to measure gene expression (RNAs) universally used before the advent of RNA-seq with lower resolution.
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a particular interesting feature is that it allows to make comparisons across multiple tumour types
at once.
• SUPPA [16] is a program developed in Python that got recently updated to calculate differential
splicing and cluster alternative splicing events according to their inclusion levels across multiple
conditions.
The alternative splicing analyses performable by the listed programs are seriously limited by their
inflexibility: they do not allow to dig deeper into the data. For instance, in all cases mentioned, clinical
data cannot be used to run survival analysis based on alternative splicing profiles. Therefore, there is a
need for a more flexible tool with the capability to process and perform proper downstream analyses of
alternative splicing in cancer through the use of an interactive graphical user interface.
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Materials and Methods
3.1 R Statistical Language
The R statistical language (also known as GNU S) is a free cross-platform programming language
dedicated to statistical and graphical computation [43]. The R language can be expanded by installing
packages available from online repositories.
RStudio [44] is a graphical Integrated Development Environment (IDE) developed to work with R.
RStudio Desktop version 0.99.903 with R 3.3.1 was used to develop all the project’s code in a machine
running OS X 10.11.6 with 4 cores and 8GB of memory. The following packages were used during
package development:
• testthat 1.0.2 to create unit tests [45];
• devtools 1.11.1 to facilitate package development [46];
• microbenchmark 1.4.2.1 to accurately measure the execution of R expressions [47];
• profVis 0.3.2 to visualise profiling data from R [48];
• rmarkdown 0.9.6 to create help documents using markdown and R code [49];
• roxygen2 5.0.1 to comment functions [50].
3.1.1 Packages
The following packages are dependencies of the program:
• data.table 1.9.6 to faster subset, update, group and perform set operations on data frames [51];
• digest 0.6.9 to compare MD5 and SHA-1 hash algorithms [52];
• DT 0.2 to render tables with filtering, sorting and searching features, among others [53];
• fastmatch 1.0-4 to reduce look-up times based on hash tables [54];
• Highcharter 0.4.0 to plot R objects using JavaScript [18].
• httr 1.1.0 to retrieve information from services that provide a Representational State Transfer
(REST) architectural style [55];
• jsonlite 0.9.21 to parse JSON data [56];
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• miscTools 0.6-16 to employ miscellaneous tools and utilities including vectorised functions of
interest [57];
• plyr 1.8.4 and dplyr 0.4.3 to manipulate and analyse data [58, 59];
• R.utils to incorporate many programming utilities [60];
• rlist 0.4.6.1 to easily work with lists [61];
• Shiny 0.14 to create a web application [19];
• shinyjs 0.6 to extend the JavaScript operations from Shiny [62];
• Sushi, a Bioconductor package, to visualise genomic data [63];
• XML to parse and generate Extensible Markup Language (XML) files [64].
Standard packages bundled with R used throughout the project bundled with R (like utils, stats and
survival) are not listed.
3.1.2 External Libraries
Shiny [19] includes the Javascript libraries jQuery 1.12.4, ion.RangeSlider 2.1.2 (slider input) and
selectize.js 0.12.1 (jQuery-based select box). Shiny also includes the Bootstrap 3.3.7 (web development
framework) and FontAwesome 4.6.3 (Cascading Style Sheets (CSS) library for icons). The package
Highcharter [18] uses Highcharts 4.2.4 (JavaScript-based plots) and the package DT [53] uses DataTa-
bles 1.10.5 (jQuery-based tables).
The minimised source code of the following JavaScript MIT-licensed libraries are included in the
package: fuzzy.js 0.1.0 for approximate string matching1 and jquery-textcomplete 1.3.4 to present text
completion suggestions from a dropdown menu2. The CSS MIT-licensed library Animate.css is also
included to provide cross-browser animations like fade in and out3.
3.2 Data Retrieval
Firehose-formatted TCGA data (like clinical information and RNA-seq junction read counts) are
retrieved from Firebrowse through its RESTful service [65]. Ensembl [66] and UniProt4 also provide
services based on a REST architecture style which are used to retrieve genetic information like genomic
position, mRNAs and proteins of a given gene. Additionally, the PubMed Central’s RESTful service is
used to retrieve research articles related to the selected alternative splicing event [67].
To retrieve data from the aforementioned RESTful services, the R package httr is used. httr makes it
easier to use HTTP methods for RESTful services like GET, POST, PUT, PATCH and DELETE [55].
3.2.1 Alternative Splicing Annotation
An alternative splicing annotation file contains the genomic coordinates of the splice junctions for
each splicing event. The annotation file for the Human genome (hg19 assembly) is provided with the
1https://github.com/bripkens/fuzzy.js (last accessed on 20 September 2016)
2https://github.com/yuku-t/jquery-textcomplete (last accessed on 20 September 2016)
3https://daneden.github.io/animate.css/ (last accessed on 20 September 2016)
4http://www.uniprot.org/help/programmatic_access (last accessed on 20 September 2016)
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package and was prepared based on the available annotations from the following alternative splicing
quantification tools: MISO [14], VAST-TOOLS [9, 34], rMATS [15] and SUPPA [16].
While the alternative splicing event annotation from MISO and VAST-TOOLS can be retrieved on-
line, the annotation from SUPPA and rMATS is only obtainable after running the programs with an
mRNA annotation file stating the coordinates of all mRNAs and respective exons. This file is down-
loadable from the University of California Santa Cruz (UCSC) Table Browser [68] in the Gene Transfer
Format (GTF) format as required by both programs. The mRNA annotation file should contain the gene
and mRNA identifiers in each line, although the gene identifier from the downloaded file is actually the
transcript identifier given a possible bug with the chosen format. To resolve this issue, we retrieved the
file in text file (TXT) to create a table with the matches between gene and transcript identifiers, replacing
the incorrect gene identifier in the GTF file.
Event annotation files from the different programs were cross-referenced and combined by matching
the chromosome, genomic coordinates and strand of the alternative splicing events. This combined anno-
tation is placed alongside the application to be used when estimating alternative splicing quantification.
Table 3.1 shows the number of annotated alternative splicing events available from each program.
Table 3.1: Annotated events retrieved from programs that quantify alternative splicing.
Alternative splicing event type VAST-TOOLS rMATS SUPPA MISO
Skipped Exon SE 142 806 45 983 48 467 47 444
Retained Intron RI 166 647 5 544 6 774 5 990
Alternative 5’ Splice Site A5SS 13 748 4 906 17 305 12 813
Alternative 3’ Splice Site A3SS 18 007 9 057 16 881 16 665
Mutually Exclusive Exon MXE 2 333 5 114 2 721
Alternative First Exon AFE 51 119 75 604 18 989
Alternative Last Exon ALE 8 958 18 748 9 863
Tandem 3’ UTRs 2 656
3.3 Alternative Splicing Quantification
Figure 3.1: Alternative splicing is quantified using (1) an alternative
splicing annotation file containing the genomic coordinates of splice
junctions and (2) a file with the number of reads aligning with each
splice junction (junction read counts) for each sample.
As previously mentioned
(subsection 2.2.2 Quantifica-
tion), alternative splicing is
quantifiable by programs such
as MISO [14], AltAnalyze
[11], VAST-TOOLS [9, 34],
rMATS [15], jSplice [35] and
SUPPA [16], but only AltAn-
alyze and jSplice accept junc-
tion read counts as input to
measure the levels of exon in-
clusion [11, 35].
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In a similar fashion, our program quantifies alternative splicing from processed data available in
online databases, thus skipping the time-consuming step of processing raw data. Alternative splicing
quantification is performed using junction quantification from TCGA and the alternative splicing anno-
tation combined from multiple sources (figure 3.1).
The PSI metric is used to quantify alternative splicing through the proportion of isoforms that include
a certain exon. This can be estimated by the ratio of normalised number of aligned reads (read counts)
that support the inclusion isoform to the normalised reads count supporting the exclusion isoform [2,32,
33]. The alternative splicing event types supported by the program and the respective formula used to
measure PSI values are summarised in table 3.2.
Table 3.2: Quantification of alternative splicing event types using junction read counts supporting the
inclusion and exclusion of an exon. C1A and AC2 represent read counts supporting junctions between a
constitutive and an alternative exon and therefore alternative exon inclusion, while C1C2 represents read
counts supporting junctions between the two constitutive exons and therefore alternative exon exclusion.
The splice junctions are illustrated in figure 3.2 for convenience.
Alternative splicing event type Acronym Quantification
Skipped exon SE Ψ =
(C1A+AC2)/2
(C1A+AC2)/2 + C1C2
Mutually exclusive exon MXE Ψ =
(C1A1 +A1C2)
(C1A1 +A1C2) + (C1A2 +A2C2)
Alternative 5’ splice site
Alternative first exon
A5SS
AFE Ψ =
AC2
AC2 + C1C2
Alternative 3’ splice site
Alternative last exon
A3SS
ALE Ψ =
C1A
C1A+ C1C2
Figure 3.2: Splicing junctions used to measure alternative splicing by event type. Alternative exons are
coloured in orange and green, while constitutive exons are coloured in blue. The green alternative exons
in alternative first and last exon events are considered as constitutive, as each event can only consist of
one alternative exon.
Splicing events with a total read count (i.e. the sum of inclusion- and exclusion-supporting read
counts) below a given threshold are discarded from the analyses. By default, this user-adjustable thresh-
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old is set to 10 reads.
3.4 Data Analyses
Principal component, survival and differential splicing analyses were employed in the exploration of
alternative splicing quantification data and their combination with clinical information, being discussed
below.
3.4.1 Principal Component Analysis
Principal component analysis (PCA) is an algorithm to reduce the number of dimensions in a data set
by rotating the variables through multiple dimensions and identifying combinations of these variables
that characterise most of the variation. These combinations are called principal components and they
allow to represent the data with a fewer number of dimensions, thus making it easier to plot and group
data samples according to the variance associated to the respective principal components [69].
When performing PCA on a data matrix, no value can be missing. Missing values have to either be
removed (implying the removal of a whole row or column) or imputed (replacing them by an operation
on remaining values, like the mean or the median). However, the removal of columns for a small number
of missing values may have the undesired effect of losing useful information. Instead, a threshold can be
defined to ensure that columns with a low number of missing values have them replaced by the median
value of the column, while columns with a large amount of missing values are discarded.
3.4.2 Survival Analysis
Survival analysis examines the expected duration of time until the occurrence of one or more events
of interest, such as death in the context of clinical data. This kind of analysis can estimate patients’
survivability in different conditions (for instance, to compare disease treatments) [70–72]. The tools to
perform and plot survival curves are built-in in R through the survival package [73, 74].
Kaplan-Meier curves are commonly used to estimate the proportion of a population that would sur-
vive a given length of time under the same circumstances, given a set of observed survival times. To test
if two curves are statistically different, the log-rank test is used [70, 72].
According to [72], different types of survival curves are used according to the event of interest:
• Overall survival curves use death as the event of interest, which provides a sense of the group
survivability;
• Disease free survival curves focus on the relapse of a disease as the event of interest and these
curves are lower than overall survival curves given that patients may have relapsed but not died;
• Progression free survival prioritise the progression of a disease (for instance, tumour growth or
spread) as the event of interest to isolate treatment outcomes from the disease;
• Disease specific survival or cause specific survival curves highlight death from the disease of
interest which may be misleading, given the limited events retrieved after removing patients that
have disease relapse or non-related deaths (this may even exclude patients that died by treatments
or other factors related to the disease).
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The clinical data retrieved from TCGA contains useful information for survival analysis including
time (in days) to patient’s last observation, death, new tumour event after initial treatment and surgical
removal, as well as drug and radiation treatment start and end times.
One important aspect of survival analysis is to track when patients drop from the study to distinguish
them from the patients that underwent an event of interest. This is relevant to data censoring. Events are
censored if they either occurred before subject enrolment (left-censoring) or, as it is more usual, if the
subject left the study or the study ended before the event occurrence (right-censoring). Censored events
are tick-marked in the survival curves [70–72].
Another type of censoring is known as interval-censored survival analysis, which is useful to study
events whose exact time of occurrence is unknown, even though data are available before and after the
event occurred. However, as none of the stakeholders is sufficiently familiar with this method, it was not
a focus of this work.
In order to explore the effects of several variables that affect survival, the proportional hazards regres-
sion analysis (also known as Cox regression model or simply Cox model) is used. The Cox model also
estimates the risk of death (hazard) for an individual given a set of prognostic variables [70]. Although
the Cox model is commonly used in survival analysis, a new statistical approach to analyse the effect of
mRNA isoform variation in survival has recently been purposed [75]. This method will be considered
for future implementation.
3.4.3 Differential Splicing Analysis
Differential splicing analysis is performed over the quantification of a given alternative splicing event
between data groups (for instance, tumour versus normal samples). It usually consists in using statistical
tests that make no assumptions about the data distribution. Such statistical tests are known as non-
parametric [76–78] and they include:
• The Wilcoxon rank-sum or Mann-Whitney U test compares the median of two groups and if the
observations in one of them tend to be larger than in the other [76, 78];
• The Wilcoxon signed-rank text performs an analysis of median ranks to access if two paired
groups belong to different populations [78];
• The Kruskal-Wallis rank sum test performs a variance analysis to check if two or more groups
are similar [76, 78];
• The Levene’s test tests for variation differences between two or more samples [79].
Although non-parametric tests are valid for most data, they generally have lower statistical power
than parametric tests. Finding the correct tools to efficiently test hypotheses from splicing data is chal-
lenging. Reportedly, the distribution of exon inclusion levels (PSI values) suggests that each exon tends
to be nearly always included or always excluded in a given cell (see figure 3.3) [80]. Therefore, it has
been purposed that PSI values follow a beta distribution [14, 81–83]. A beta regression can then be used
to model exon inclusion levels directly, using the R package betareg [83–85] that can be integrated in the
future.
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Figure 3.3: PSI distribution
of splicing events from highly
expressed genes in individ-
ual cells (top) and populations
(bottom). Adapted from [80].
Given the sheer amount of splicing events profiled, significance
must be corrected for multiple testing. The application can apply sev-
eral p-value adjustment methods from the family-wise error rate (Bon-
ferroni, Holm, Hochberg and Hommel corrections) and false discovery
rate (Benjamini-Hochberg and Benjamini-Yekutieli methods) [86].
3.5 Version Control
Version Control Systems (VCSs) allow to track each change made
to a working repository and make it easy to check the code history and
to revert a bad change [87]. One of the most popular VCSs is git for
its high-level abstraction compared to older VCSs [88]. The project
makes use of git and it is hosted as a public repository in GitHub5.
RStudio supports common tasks of version control with git, includ-
ing: (un)stage changes, commit changes, amend last commit, show
history log, show file diffs, push and pull, among others [89].
3.6 Testing Tools
3.6.1 Continuous Integration and Code Coverage
After each change to the GitHub repository, the Continuous Integration (CI) software Travis-CI runs
R CMD build and R CMD check on the project6. This ensures the package can be built from scratch.
Travis-CI tests the package in virtual machines running Ubuntu 12.04.5 LTS Server Edition (64-bit) with
2 cores and 7.5GB of memory7.
In the end of the automated build, Travis-CI runs CodeCov, a remotely hosted tool that tests a
project’s code coverage, i.e. what lines of code are being tested or not by the unit tests8.
The CI service AppVeyor is used to build and test the package on a virtual machine using Windows
Server 2012 R2 (64-bit) with 2 cores and 4GB of memory9.
3.6.2 Benchmarking
To measure the time to load data, quantify alternative splicing (skipped exon) and perform differential
splicing analysis, normal versus tumour comparisons were separately run 10 times with the same settings
for different tumour types in a machine running OS X 10.11.6 with 4 cores and 8GB of memory. The
visual interface of the program was run in Safari 10.0 and RStudio Desktop version 0.99.903 with R
3.3.1.
5https://github.com/nuno-agostinho/psichomics
6These commands need to pass with no errors or warnings for the package to be accepted in Bioconductor (subsection 4.1.1)
7https://docs.travis-ci.com/user/ci-environment/ (last accessed on 14 September 2016)
8https://codecov.io (last accessed on 14 September 2016)
9https://www.appveyor.com (last accessed on 14 September 2016)
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3.6.3 Usability Testing
Usability testing was performed with 6 members of the Computational Biology Lab at Instituto de
Medicina Molecular. The test sessions were conducted according to a detailed script (see section C.1:
Script) on a machine running Ubuntu 14.04.4 LTS (64-bit) with 32 cores and 264 GB of memory. The
program was run in Firefox 47.0 from RStudio 0.99.902 running R 3.3.1. Each test session lasted between
1.3 to 2 hours.
18
Chapter 4
Design Decisions
4.1 Programming Language
The free and open-source R programming language focuses on statistical and graphical computa-
tion interpreted by a console. The basic functionality of R can be expanded by packages available in
online repositories such as The Comprehensive R Archive Network (CRAN) (a general repository of R
packages) and Bioconductor (dedicated to store R packages related to biological data analyses [17]).
The R language was chosen over other more commonly-used languages in program development
(like Java, C++ or Python) given the interest of the scientific community in R and Bioconductor and
the diverse R packages that satisfy many biological data analyses that can be integrated in the package
[90–92]. The prospect of biologists contributing with code for custom analysis also influenced this
decision. Although there are projects like rpy2 that run R code embedded in a Python process1, these
community projects have limitations and compatibility problems with some R packages, which may
hinder their adoption.
Nevertheless, one of the major limitations of R is the low performance compared to lower-level
languages, even though it is possible to mitigate it when using packages like BiocParallel for parallel
programming and Rcpp to run C++ code from R [93].
On the other hand, a significant motivation to develop in R is the Shiny package [19], a web applica-
tion framework that allows to create an entire web app using only R code but also allowing to add custom
HyperText Markup Language (HTML), CSS and Javascript for more complex applications. Shiny fol-
lows a reactive programming model where the output is bound to the input (reactive dependency) and,
every time the input changes, the output automatically updates as well according to the new input [19].
Most R packages can be used within Shiny including JavaScript-based packages that allow for graphical
visualisations.
4.1.1 Bioconductor’s Package Guidelines
Given that R was selected as the primary programming language, it was also decided to submit the
program as an R package to Bioconductor. Bioconductor is an online repository of R packages focused
on computational biology and bioinformatics [17] widely used for biological data analysis [92, 94, 95].
1http://rpy.sourceforge.net (last accessed on 28 August 2016)
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The approval of new packages in Bioconductor must follow guidelines2, including:
• There must be no errors or warnings when building (R CMD build), checking the package
for problem issues (R CMD check) and running Bioconductor-specific package checks (R CMD
BiocCheck);
• The package size built by R CMD build must be less than 4 MB;
• R CMD check must complete within 5 minutes;
• The package must contain documentation illustrating the major uses of the package and compre-
hensive help pages for exported functions;
• The package must not contain code from third-parties that cannot be distributed under the specified
license;
• The package must include release notes;
• The package can only depend on R packages available in either CRAN or Bioconductor (a specially
limiting requirement).
4.2 Prototype
Before defining the architecture of the application, a prototype was developed to test R, Shiny and the
IDE RStudio. Both the prototype and the book [96] allowed to understand more about the R language.
For instance, I learned through them how object-oriented and functional programming works in R. A
mixed approach using both paradigms was also tested as [97] suggests but one of its negative aspects is
that object-oriented programming in R is much more verbose than in languages like Java and C++. Also,
methods are related to functions instead of classes as in traditional object-oriented languages [98].
It is also fundamental to know that, when the user loads an R package, all its functions are loaded as
well. However, the source files from the package are not available, only its functions. R also does not
support function overloading (functions with the same name but distinct implementation) in the same
namespace.
4.2.1 Debugging
R offers specialised debugging functions to fix bugs in the code. One example is browser(), which
opens a debugging session at an arbitrary code line. This debugging session allows to interactively run
arbitrary code from the console and browse the code using commands to execute the next line in a
function, step into a called function, finish the execution of the current loop or function and continue
regular command execution by exiting the debugging session. RStudio extends the debugging tool by
contextually highlighting the debugged line in the source file and showing all defined variables and their
corresponding values in the current context [96].
2Available at https://www.bioconductor.org/developers/package-submission/ (last accessed on 12
September 2016)
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4.2.2 Code Performance
Performance can be measured using packages like microbenchmark to compare multiple runs of
different R expressions or functions [47].
To improve code performance in R, it is usual to use vectorised functions which are much faster than
running the same code in a for loop. Since the for loops used in vectorised functions are written in C,
they have comparatively less overhead. There are many vectorised functions for most common cases in
R and for those cases when there is no appropriate vectorised function, it is possible to write one in a
language such as C++ using the package Rcpp [93, 96]. Yet another way to improve the performance of
a function is to use the byte code compiler integrated. This is integrated in R and allows to compile a
function to improve its speed, with execution times comparable to a C version of the same function [96].
There are other practices to improve performance which are more akin to other programming lan-
guages. For instance, instead of growing an object like a list in a for loop, it is better to allocate the
space required for the object before and modify each object’s element in-place [96]. Another example is
parallelisation which is supported by the built-in R package parallel [43, 96].
4.2.3 R Packages
R has a set of conventions to create packages that are easily installable in other computers. One of
the best reference books about R packages is [98]. This book is divided in chapters according to the
organisation of an R package describing each folder and file at the top-level of a package:
• R/ folder for code (i.e. R files)
• DESCRIPTION file for package metadata including package description, dependencies, licence,
file loading order and author contact information
• NAMESPACE file for a list of exported functions (i.e. functions meant to be used by end-users) and
functions used from other packages
• man/ folder for object documentation
• tests/ folder for unit tests
• vignettes/ folder for package tutorials and guides
• data/ folder for data to be used by the end-users
• src/ folder for compiled code (like C++ code)
• inst/ folder for extra files like external data not to be used by the user, citation information and
non-R source files
The best friend of an R package developer is the package devtools, given that it has dedicated func-
tions to test the package, properly document the package and its functions, run the examples given in
the function comments, create package tutorials and guides (known as vignettes) and build the package
itself [46].
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Code
R packages require files to be stored directly in the R folder to be tested, documented and built in
the package. Any files outside this folder or even inside its subdirectories are not tested, documented
and built in the package. This is a major problem regarding code organisation. To solve this, files have a
shared prefix in its name to define their ”folder”. Still, this leaves the R folder containing many files.
R packages are distributed through a binary package where the functions from the R files are effi-
ciently stored but the original source files are not available. R loads all those functions when loading a
package.
Package Dependencies
There are two types of package dependencies: the packages that must be present for the package
of interest to work (imported packages) and the packages that are not critical (suggested packages).
Imported packages are automatically installed alongside the package of interest, while the suggested
packages need to be installed by the user. It is also possible to indicate the minimum version required of
a package. All package dependencies must be stated in the DESCRIPTION file.
Object Documentation
Object documentation is important to declare how functions work. Specifically in R, functions are
documented by writing an individual file based on LaTeX located in the man folder [98]. Although
creating a separate file in LaTeX for each function may seem too much work, the R package roxygen2
can handle this. With this package, the developer just needs to create roxygen comments (comments with
special prefix and tags) before a given function and run a specific roxygen2 function to create or update
the documentation files [50].
A roxygen comment for a function may include a title, a description, type and description of pa-
rameters, examples3 and description of the function output. The available tags allow to identify these
different sections and many more which can include formatted text like bold, italics and links. Docu-
mentation may be applied to datasets and to packages as well and, in the case of packages, it provides a
way to describe the most important package components [98].
Documentation also allows to state which functions are accessible when loading the package (ex-
ported functions) and which are only for internal use (non-exported or internal functions)4 [98].
By default, R loads all functions in files by alphabetical order of the files when loading a package.
Although it is possible to change the loading order manually, roxygen2 makes it easier [50].
Vignettes
Vignettes are additional documentation more akin to a guide or a tutorial. Instead of describing a
function or a package like object documentation, vignettes elucidate the problems that can be solved with
a given package, discussing the most useful functions that are available and how to use them. Vignettes
3These examples are run by default to ensure the code is valid.
4Note that external functions are the ones that should be used by people who are using the package. It is still possible to use
non-exported functions.
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are written in Markdown, a plain text format that can be converted to HTML. The R package rmarkdown
combines Markdown text, runnable R code and respective results [98]. Most of the work I developed
was written down in vignettes, making it easier to explain certain steps of the package development.
4.2.4 Shiny
Shiny is an R package that works as a framework for web applications [19]. When starting a Shiny
app, a localhost connection opens and is accessible through a web browser while the calculations are
processed in an R session.
Shiny follows a reactive programming model where the output (for example, a plot) is bound to two
specific inputs (for instance, the data to be plotted and the range of the X axis), so that every time the
input is modified, the output is updated to reflect those changes in a so-called reactive dependency. All
the input and output objects are recognised by a given unique identifier. Shiny makes writing the user
interface easier by providing functions that are essentially wrappers to HTML code. Some functions are
higher-level (e.g. it is easy to implement common input elements like radio buttons and checkboxes), but
Shiny supports any kind of HTML tag.
Shiny also allows to directly include HTML, CSS and JavaScript elements in the application. HTML
is a language used to structure the content of a page while CSS allows to style the HTML elements
by their class, identifier and other attributes. JavaScript is the language used in web design to perform
calculations and add interactivity to the web pages. It can also access the HTML elements by their
attributes.
Shiny makes use of Bootstrap 35. Bootstrap is a free and open-source HTML, CSS and JavaScript
framework that includes many design templates for styling input elements, progress bars, navigation bars
and other common elements in web pages.
The suggested folder organisation for a Shiny app includes the file(s) that starts the app, the user
interface and server logic in the top-level directory, as well as a www folder containing the styling files
(CSS) and external JavaScript libraries. However, this recommendation does not work for packages
because custom top-level directories are not included after the package is built for distribution. Therefore,
all R files are placed in the R folder while other files and folders are moved to the inst folder6.
4.3 Requirement analysis
As previously mentioned in section 1.1: Requirements, the discussions with the stakeholders allowed
to understand the requirements of the program, which were divided in the usual categories — functional
and non-functional. The following list presents the functional requirements:
• Retrieve data (like clinical information and molecular data) from online sources such as TCGA
– Ability for an administrator to allow data retrieval from other databases
• Unarchive downloaded data if needed (as in the case of TCGA data)
5http://shiny.rstudio.com/articles/css.html (last accessed on 1 September 2016)
6http://shiny.rstudio.com/articles/html-ui.html (last accessed on 1 September 2016)
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• Identify and load data according to their file formats
– Ability for an administrator to add support for new file formats
• Manipulate data (including alternative splicing quantification from data) input
– Ability for an administrator to create new data processing tools
• Perform statistical analyses (e.g. survival, principal component and differential splicing analyses)
and plot associated graphical elements (with a focus on user interactivity), saving results
– Ability for the end-user to save results
– Ability for the end-user to also create clinical groups to use in the analyses
– Ability for an administrator to add new data analyses and visualisations
Figure 4.1: System use case diagram. Syntax based on Unified Modeling Language (UML).
These functional requirements were organised in the use cases presented in figure 4.1. The following
list presents the quality attribute requirements:
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• Modifiability — easy to modify and introduce new system components, such as adding support
for new file formats and for new analyses and visualisations;
• Usability — easy-to-use and consistent interface, with informative error and warning messages;
• Performance — focus on time taken by each operation, given the amount of data to process and
analyse;
• Responsiveness — inform the user if an operation is taking place (for instance, show task progress
and disable the button that starts an action during a task).
4.4 Architecture
An important step of software design is the creation of an appropriate architecture, more easily
achievable with a careful reflection on the program’s requirements (section 4.3: Requirement analysis).
In turn, the architecture promotes discussions about the best approach to follow with the stakeholders
that more closely aligns with the requirements [99].
Figure 4.2: Logical view. The user has three options of data input: to
retrieve TCGA data within the program, with the annotation of alternative
splicing events either loaded by the user or provided by the program (a);
to directly retrieve data and load it in the program (b); or to directly load
the quantification of alternative splicing events, bypassing the loading
of junction read counts (c). Each module comprises one or more files
designed for a dedicated activity.
One of the first steps
taken was to research previ-
ous architectural design im-
plemented in R to be aware
of any major difficulties I
could find. I actually did not
find any research article re-
lated to R architecture, al-
though other functional lan-
guages such as Haskell have
literature on the topic. I
initially proposed an archi-
tecture based on an hierar-
chy of file sourcing where
the modules would load their
sub-modules but this could
not work as an R package
because packages are binary
and there is no access to their
source files, only to its func-
tions. This approach was
inspired by how other lan-
guages work and reflected
how little I knew about R package development and reinforced the importance of properly knowing
a language and the respective developmental process before planning its architecture.
Based on the requirements, the logical view in figure 4.2 depicts how the application was designed
to work from the end-user’s perspective.
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Given that modifiability is desired to easily extend and introduce new analyses and visualisations,
the application was designed to be modular (i.e. to comprise independent components, which also makes
unit testing easier) and extensible in order to allow the introduction of new features with little or no
change of the program’s core functionality. With knowledge on R and Shiny, a developer can follow
simple template files to create new modules for the application.
Modifiability promotes the evolution of the application by making it easy for any fellow program-
mer (and maybe even biologists) to collaborate on new functionalities, thereby increasing its interest
to the scientific community. Also of interest, the use of functional programming may contribute to the
application’s desired modularity and effortless testability as it characteristically reduces the problem into
easier-to-tackle sub-problems [100]. Both modularity and extensibility contribute to a more maintainable
program by making it easier to apply modifications or bug fixes.
Figure 4.3: Development view. The top-level directory organisation of the program is conditioned by
the structure of packages in R (see subsection 4.2.3: R Packages). Pseudo folder refers to the fact that
source files cannot be inside subdirectories. As an alternative, filename prefixes are used to indicate the
”folder” of a file. The pseudo-folder Data encompasses data retrieval and manipulation.
The most desirably modifiable parts of the system were mentioned in section 4.3: Requirement
analysis: any interested developer should be able to add new modules to retrieve data from new online
databases (data retrieval), support new file formats (formats), create new data processing and manipu-
lation tools (data manipulation) and perform new data analyses and visualisations (analyses). In order
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to do so, the system is decomposed in three parts: data input and manipulation (given their similar im-
plementation), data loading and data analyses and visualisations. Also, to provide a complete alternative
splicing annotation to the user, a collection of functions were created to parse the output from the differ-
ent commonly used programs for alternative splicing analysis (events; read subsection 3.2.1: Alternative
Splicing Annotation). This parsing is not part of the program’s runtime. In the future, this may be used
to cross-reference alternative splicing events shown in the application with those from other programs.
Figure 4.3 depicts the modular organisation of the program’s code.
Another important consideration is usability as a good user interface is crucial to user satisfaction.
This program is intended to be used by anyone interested in studying alternative splicing, particularly
researchers with no computational background. Given that one of the main goals of this work is to build
a tool to be used by the scientific community, the application needs to provide what the users of this field
expect in an intuitive way to be successful. This includes finding ways to help the user select data and
display them in an interactive and intelligible manner.
All of these attributes were taken into consideration while designing and implementing the applica-
tion. Following many discussions with the stakeholders about the analyses and interface and through
an iterative development, we agreed on the architecture illustrated in figures 4.2 and 4.3 and further
described in the remaining sections of this document.
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The proposed application tries to satisfy any interested user that desires to study alternative splicing
in cancer. The application contains a graphical user interface through which users can load, process,
filter and analyse tumour data available from online databases in an easy and intuitive manner.
5.1 Modularity
Recently, Shiny was updated to standardise the usage of independent modules. These modules are
comprised by a server logic and an user interface that can be called by other modules. Each module also
employs its own namespace to avoid conflicts when sharing identifiers for input and output objects in
distinct modules.
Before the introduction of Shiny modules, I was working on a similar implementation based on R
environments (each environment is a collection of independent variables). My implementation ensured
a hierarchy of environments where each submodule loaded its functions to an environment encapsulated
in the environment of the calling module. This actually had a pretty significant improvement over Shiny
modules as functions from different environments could have the exact same name, given that R does not
allow function overloading per environment. However, this is not applicable to packages as, when an R
package is loaded, all its functions are loaded overriding homonymous functions. Since both implemen-
tations were similar in this context, the implementation of the Shiny modules was preferred for being the
standard.
The architecture of the program was designed to have a primary function called by the user that calls
all the user interface and server logic of each complying module assigned to the primary function. In
their turn, these modules call the functions for which they are responsible, and so on.
To assign which functions call which, each function has an extra attribute stating its caller function.
This is possible given that any R object (including functions) is a container of publicly-accessible at-
tributes, allowing to develop the mentioned hierarchy by attributing a string recognisable by a specific
user interface or server logic functions. The caller’s user interface function will call all the user interface
functions with the given string and the same for the server logic. Also, a prioritise functionality was
incorporated to change the loading order of functions (by default, functions are loaded alphabetically).
New modules can be easily added by following the existing templates without the need to modify
any other file. For instance, check the code in section A.2: Template for an Analysis File.
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When the user loads the project’s package, they can either use the exported functions in the command
line or launch the visual interface to use the program’s functionality. The visual interface launches in the
user’s default browser by calling the function psichomics()1. This function also triggers a series of
hierarchical calls to prepare the interface and server logic of the application (figure 5.1).
Figure 5.1: Call hierarchy for the interface and server logic functions. The call hierarchy is triggered by
calling psichomics(). The icons represent functions called to create data groups (either the interface
or the server logic, depending on the caller function).
As the functions for the user interface and server logic can be included in a single file, I decided
against decoupling them in order to simply have one module’s responsibility for each file. Since files in
the R folder cannot rely on subdirectories to help in the organisation, I found it more appropriate to use
one file to represent one module. Still, it is actually possible to use separate files.
5.1.1 Communication
All the variables are accessible through a special global reactive variable, specific to Shiny, that
holds all the information during the runtime of the program. This variable is a list containing the loaded
datasets, groups and global configurations. In order to abstract how data in the global variable are re-
trieved and set, dedicated accessor/getter and mutator/setter functions were created, being located in the
file specific to global access functions (figure 4.3).
1As previously mentioned, PSIchomics is the name of the project.
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5.2 Data Input
As previously mentioned in section 3.3: Alternative Splicing Quantification, the data required for the
quantification of alternative splicing events are the junction read counts from the samples of interest and
the alternative splicing event annotation. The latter is provided in the package, although only for Hu-
man (hg19 assembly). Besides, the user may also load the alternative splicing quantification previously
calculated with this program.
The following subsections discuss how the data required for alternative splicing quantification are
retrieved and loaded.
5.2.1 Junction Read Counts and Clinical Data
TCGA is a project that aims to collect data from patients with diverse tumour types. TCGA contains
tumour transcriptomic data, including junction read counts and patient clinical information. Most of the
data from TCGA is freely accessible through a RESTful service which allows to query and download
the available datasets2. However, data from TCGA is organised as one file per clinical sample, requiring
merging the results of all these files per data type (i.e. type of molecular profile) before data processing.
Fortunately, Firehose hosts data from all the TCGA samples of each cancer type merged into a single
file per type of molecular profile. There is an R package to programatically retrieve the data, called Fire-
browser [20]. However, this package is not available in neither CRAN nor Bioconductor. Considering
the project is going to be submitted to Bioconductor, it cannot depend on packages unavailable in these
repositories (see subsection 4.1.1: Bioconductor’s Package Guidelines).
Firehose data is also accessible through Firebrowse’s RESTful service which allows to retrieve data
per data type, tumour type and data’s date stamp [65]. This service was used to retrieve TCGA data
of interest like clinical information and read counts for alternative splicing junctions. Querying Fire-
browse’s RESTful service returns a JavaScript Object Notation (JSON) file containing links to download
gzip-compressed tar archives (one archive per data type per tumour type). The service also includes MD5
files that are used by the program to check the integrity of the downloaded archives.
The program’s interface allows to select tumour type (also known as cohort), data’s date stamp, type
of data to retrieve (e.g. clinical data and junction quantification) and the folder where data are stored.
The type of data to retrieve is an actual simplification of two Firebrowse fields. Instead of having the
user select the correct combination of fields to get the data, it allows the user to select data of interest
directly. For instance, the user can just select ”Junction quantification (RNA-Seq)” which appropriately
queries Firebrowse for junction quantification from RNA-seq.
As Shiny is only able to sequentially download files and the interface becomes unresponsive when
transferring large files, file downloading is handled by the web browser. However, this implies that the
user must understand that the files are being downloaded and that the program needs to be notified when
the downloads have finished to continue processing them. To inform this to the user, a modal dialog
instructs on how to proceed when the downloads finish (see subsection 5.4.1: Modals).
If all the requested data are available in the user’s computer, the downloaded archives are extracted
to folders named with the respective tumour type and date stamp for organisation purposes. Finally, the
2https://wiki.nci.nih.gov/display/TCGA/Web+Services (last accessed on 10 September 2016)
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Figure 5.2: TCGA data retrieval. If any of the files required for processing is unavailable in the given
folder, they are downloaded. Otherwise, files are loaded.
files inside those folders are loaded to the application.
Clinical information is contained inside a Tab-separated Values (TSV) file with multiple rows char-
acterising each clinical patient (column) of a given tumour type, while junction quantification is available
as a TSV file showing the junctions (rows) and the sample identifier (columns). As a patient may have
more than one associated sample, multiple columns in the clinical information indicate the sample iden-
tifier. A simple search in the columns where sample identifiers are present allow to associate patients and
samples.
5.2.2 Alternative Splicing Event Annotation
The human alternative splicing event annotation (hg19/GRCh37 assembly) provided in this program
is retrieved from diverse programs: MISO [14], VAST-TOOLS [9,34], rMATS [15] and SUPPA [16]. The
annotation files from MISO and VAST-TOOLS are available online while SUPPA and rMATS require to
run their software using mRNA annotation — a file containing the genomic coordinates of all transcripts
and respective exons, downloadable from the UCSC Table Browser [68].
Although it is possible to create the alternative splicing event annotation file with functions within
the program, the visual interface does not accommodate this as it was planned that the annotation would
be provided to the user (even though the user can still load his/her own annotation file).
Unfortunately, the inclusion of the combined annotation file makes the package larger than the 4
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MB limit of Bioconductor (subsection 4.1.1: Bioconductor’s Package Guidelines), so this file will be
provided instead as an annotation package in Bioconductor3.
5.2.3 Dataset Loading
Dataset loading progresses in two steps: (1) check the format of a file and (2) load the file according to
its format’s instructions (figure 5.3). Each format of interest has its own R file to describe its properties,
including the header of the file, the name of the file and how to load it, among many other attributes,
in order to accommodate a wide range of file formats. For consistency with the remaining project,
the language of the source code is R, instead of XML, JSON or a custom domain-specific language.
The source code that defines a file format contains a function that returns a named list (also known as
associative array, dictionary and key-value pair in other programming languages). This list determines
the file format’s properties (see the source of the clinical data format in section A.1: Format of the
Clinical Information).
Figure 5.3: File format checking (top) and file loading (bottom). Each file is checked against the available
file formats. If only one format returns positive for a file, that file will be loaded according to the format’s
instructions.
When checking the format of a file, only the first lines4 of the file are loaded. A file is matched to a
3Annotation packages do not have size limit.
4By default, it loads the first 6 lines of the file. This can be changed in the format’s attributes.
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format if the format’s string and a specific row or column of the file are consistent. Optionally, a partial
match for the filename may be additionally requested. Currently, only three file formats from TCGA are
loadable by our program: junction quantification, gene expression5 and clinical data files.
If a file’s format is identified, the file is loaded according to the matching format’s instructions (bot-
tom of figure 5.3). R loads files by automatically recognising each column type (string or numeric) but
this does not work when the file has a header made of strings. So, instead of loading the whole file, re-
moving the rows containing strings, adding the desired row as a header and converting all the R object’s
columns to numbers, it is an order of magnitude faster to load the file without those first lines with strings
and then load what was skipped and use it as the header. Also, duplicated rows can be removed. This is
faster if row names are available, as they are required to be unique and duplicated values can immediately
be identified. However, if a column of unique values is not available, rows need to be compared one by
one in a much slower process.
5.3 Analyses
5.3.1 Interactive Plots
An important tool to create interactive elements in Shiny is the package htmlwidgets that makes it
easy to wrap JavaScript libraries in R [101]. Currently, about 70 htmlwidgets-based HTML widgets are
hosted in CRAN6.
Many R packages were explored to look for a package able to create diverse types of different
plots (for example, able to create general plots like bar and scatter plots and more specialised plots
like heatmaps and survival curves). Having a package able to perform a wide number of plots allows
for interaction consistency (for instance, different plots share the same way of zooming) and is easier to
develop with (each package has their own functions and it can be time-consuming to learn how to plot
different charts in the different packages).
ggplot2 is a very popular and extensible plotting system in R to create diverse types of static plots
[102]. ggplot2 comes with some rather basic functionality for user interactivity in Shiny apps. It includes
functions to retrieve the location and data associated with the element hovered, clicked and double-
clicked by the user and also a brushing feature that allows the user to draw a rectangle selection on the
plot. It can even zoom and return points near a mouse event or a brushing area [102].
Many packages extend ggplot2’s functionality and such is the case with ggiraph and ggvis, that
include contextual tooltips and support JavaScript click events on data points but are limited to few types
of plots. plotly is another package that also extends ggplot2 and natively generates scientific plots such
as survival curves and heat maps. When the appreciation of these graphical tools was made, the use of
plotly required authentication and an internet connection to publicly upload plots (with a limited number
of private plots for the free account) which made me put the package aside. This is not true anymore
since plotly can now be used independently of authentication and online access.
rCharts is an R package that aggregates many different JavaScript libraries which do not share much
consistency between them (as already mentioned, it is more time-consuming to develop using different
5Gene expression is presently not supported in subsequent analyses.
6See http://gallery.htmlwidgets.org (last accessed on 4 September 2016)
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libraries and the interactions are not the same between plots of different libraries). An even bigger
problem of this package is the scarce documentation available, which limits its potential.
d3heatmap is an implementation of a heat map including a dendrogram based on the D3 JavaScript
library. Although it only plots heat maps, this type of interactive plots are overlooked by other packages.
Besides, it allows zooming and contextual tooltips on hover. Another interesting package is edgebundleR
that only creates interactive circle plots.
Metricsgraphics is based on MetricsGraphics.js, a JavaScript library built on top of the D3 JavaScript
library. It features pretty plots, customisable contextual menu on data hovering and seamless data updat-
ing. However, data zooming is an add-on and notably slow. Besides, MetricsGraphics.js only focuses on
line charts, even though the experimental scatterplots, bar plots and column plots are nicely done7.
There is an R package named Highcharter which is a wrapper to Highcharts, a JavaScript library
free for non-comercial use [18]. Highcharts supports tooltip on hover, zooming, omitting series and
exporting the plot to common image formats such as PNG, among other features. More impressive yet
is the array of plot types available through Highcharts: line, area, column, bar, pie, scatter and bubble
charts, heat and tree maps, boxplots, polygon series and it even allows free drawing8. All these charts
are highly customisable and available in the R package. For this reason, Highcharter was chosen as the
primary plotting library to render most interactive plots.
5.3.2 Principal Component Analysis
The current implementation of the PCA module allows to standardise and scale the data, impute
or remove missing values according to a given threshold and perform PCA on the alternative splicing
quantification data to explore groups between data samples.
To perform a PCA, the program uses the function prcomp from the built-in package stats, resulting
in an object of the class prcomp. As already mentioned, R objects are essentially a list of attributes and
it is easy to retrieve information from this object to render a scatter plot using two principal components
(X and Y axis) with Highcharter. Unfortunately, adding attributes to the individual data points (such
as the sample identifier in this case) was not available in Highcharter so a modification to an existing
function in Highcharter was sent as a pull request and accepted. It is now available in the lastest release
of Highcharter in CRAN.
It is also possible to colour samples according to their clinical attributes (e.g. tumour stage, gender
and race) by creating groups of data. More information is available in subsection 5.4.2: Data Grouping.
To easily visualise the principal components, the proportion of variance explained by each principal
component are represented both graphically and textually.
5.3.3 Survival Analysis
The survival analysis module allows to analyse patient survival using Kaplan-Meier curves and by
fitting a Cox proportional hazards model. These two analyses have dedicated buttons, given that the input
they receive may be slightly different. The statistical significance of differences between Kaplan-Meier
curves is also calculated when plotting the curves using the survdiff() function from the survival
7http://metricsgraphicsjs.org (last accessed on 4 September 2016)
8http://www.highcharts.com/demo (last accessed on 4 September 2016)
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package and information associated with each curve (number of patients and events) is available in the
plot’s tooltip.
The output of the survival analysis using follow-up time (or start and end times in case of interval-
censored data) and event occurrence through the survfit() function (survival package) is an R object
of the class survfit which can be used as input to the function plot.survfit() for a static plot. To
create interactive plots, the function plot.survfit() was studied and simplified so the R object
could be plotted with Highcharter instead (figure 5.4). The code for the Highcharter plot was submitted
as a pull request and accepted in the development version of the Highcharter package.
(a) Static (left) and interactive (right) Kaplan-Meier
curves
(b) Static (left) and interactive (right) cumulative haz-
ard curves
Figure 5.4: Comparison of survival curves comparison as plotted using the function plot.survfit()
from the package survival and Highcharter.
To calculate the fit of a Cox model to the clinical data, both follow-up time and event occurrence are
passed to the coxph function from the survival package. The follow-up time is simply the time when
an event occurred or otherwise the time when the patient has last been observed (censored).
To model the terms of the Kaplan-Meier curves or the Cox model fit, the user can visually create
groups based on the clinical data (say by tumour stages or ethnicity) to analyse differences in survival
(see subsection 5.4.2: Data Grouping). More advanced users may prefer to insert an expression to analyse
survival data (as it is usual in R) to explore interactions between clinical groups for Cox models. When
inputting a formula, the clinical attributes available are accessible through text suggestions (see section
subsection 5.4.3: Text Suggestions). The expression is written in a text box and the resulting string is
parsed to run in R. In case there are parsing errors, the user is notified.
Survival analyses can also be used to study the impact of alternative splicing in prognosis using
the PSI cut-offs to group samples based on an alternative splicing event. Using the R built-in function
optim(), multiple cut-offs are tested for each selected event and the one maximising the significance
of difference in survival (i.e. minimising the p-value of the log-rank test) between the two groups is
returned. However, it should be noted that although the optim() is relatively fast, it may return a local
maximum.
5.3.4 Differential Splicing Analysis
Differential splicing analysis has been divided into two submodules. The first one is responsible
for performing statistical tests on the PSI differences between groups of samples for all the alternative
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splicing events and returns a table with the relevant results. This table can be saved by the user as a TSV
file. Contrastingly, the other module displays the results of the statistical tests for each individual event.
Figure 5.5: Example of a density plot containing a rug plot at
the bottom. The distributions of alternative splicing quantifi-
cations for this splicing event over the different tumour stages
show an increase of the median value (represented by the ver-
tical dashed line) with maligancy.
Both submodules are accompanied
by density plots so the user can observe
the distributions of alternative splicing
quantifications for each group and vi-
sually compare them (figure 5.5). To
avoid difficulties in interpreting low-
resolution density plots resulting from
small sample sizes, the data points may
be plotted near the axis as a visual guide
for the user to broadly understand the
variance and number of samples con-
tributing to each curve. This plot is
known as a rug plot.
Highcharter does not possess any
function to render density plots but they
are rather easy to create. The code to
create them was sent as a pull request
to the GitHub repository of Highchar-
ter and it is now available in the latest
release.
The table containing results of the
statistical analyses for all the splicing events can be filtered by their values or the spicing events’ attributes
(e.g. chromosome, strand and associated gene). It also possesses a column with the density plot estimated
with 10 points from each group for each splicing event for performance reasons (compare this with the
512 points used by the density plots for single events). The splicing event, the identifier and the density
plot are both clickable and take the user to its differential splicing analysis, allowing the user to focus on
the statistical information available for that event alone.
The density column in DataTables does not use the Highcharter package as it does not support ren-
dering plots inside DataTables. In order to circumvent this limitation, I had to rethink my approach. As
Highcharts transforms JSON code to the JavaScript-based plots, Highcharter is used to obtain the JSON
code for the plots. Next, the JSON code is injected in HTML code as a string and added as a column
of the table. The table has an associated callback to render the plots of the visible rows before drawing
those rows on the screen.
5.3.5 Gene, Transcript and Protein Information
This section of the program allows to retrieve information from the gene, its transcripts (i.e. mRNAs)
and respective proteins for the selected alternative splicing event. The information is concise, showing
the gene name, a brief description of its function and its genomic position. Schemes of its transcripts
and protein domains are also plotted. It also features links to appropriate external biological databases
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such as Ensembl (genomic information [103]), UniProt (protein information [104]) and UCSC Genome
Browser (genomic information visualiser [105]) based on the gene coordinates or the protein identifier.
Also, relevant articles from PubMed Central (a central repository of literature in life sciences [67])
are retrieved based on the gene symbol (a gene’s unique identifier), the term cancer and the names of the
datasets loaded by the user (e.g. breast invasive carcinoma).
All the information presented therein is retrieved from the Ensembl and UniProt RESTful services
as depicted in figure 5.6. The user-selected alternative splicing event’s gene symbol is used to query
Ensembl’s RESTful service for more information. Ensembl returns information regarding the gene,
its transcripts and the transcripts’ respective proteins [66]. This Ensembl protein identifier is matched
against UniProt to retrieve protein features such as domains and structure [104]. UniProt proteins from
both TrEmbl and Swiss-Prot are retrieved.
Figure 5.6: Process view of how the information on genes, transcripts and proteins is retrieved from
Ensembl and UniProt RESTful services.
One of the first ideas for this section included embedding an HTML5 genome browser such as Dal-
liance, which uses Ensembl as one of its databases of reference [106]. This way, the browser view could
be set to the gene coordinates but the user could still see surrounding genes, transcripts and proteins
by dragging or scrolling the view. Unfortunately, the HTML5 or JavaScript genome browsers found
either do not work in Shiny (such is the case of Dalliance) or do not provide a customisable and simple
interface.
The transcripts are currently drawn using the R package Sushi, which results in static plots represent-
ing different transcripts (figure B.7b). Sushi requires as input the transcripts’ identifiers, chromosomes,
strands and the respective exons’ start and end positions. Sushi is also able to draw a region over the
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alternative splicing event of interest, allowing the user to check if the event is supported by transcripts
from Ensembl. Unfortunately, trying to plot the same transcripts but altering the X axis to show only
the alternative splicing event shows no transcript unless the transcript’s start or end coordinate is within
that region. This seems like an odd oversight and I find it an incentive to develop an interactive plot to
replace the static one currently used.
To draw the protein features, the R package Highcharter was used. Only one protein can be selected
at a time to have its features drawn. Each feature type from the protein returned by UniProt is represented
as a separate series (figure B.7c). This way, the user can omit or show types of features from the plot as
desired. For visual differentiation, each series has its own colour9 and Y value. The differing Y value
avoids overlaps between multiple data series.
The differing types of features also hold characteristic information. For instance, some features
indicate an annotated change in a protein, its type and a brief description, while other features only
present the description. To check this information, the user needs to hover over the feature of interest
and the tooltip will present all the information available from the UniProt RESTful service regarding that
particular feature.
Welcome future additions include a feature comparison between different proteins and highlighting
the protein region affected by the selected alternative splicing event to better understand the protein
features potentially affected by it.
5.4 Supporting Features
There are other supporting software features to ensure the application offers a consistent and intuitive
interface. Some features such as explanatory progress bars are necessary so that thee user understands the
steps and progress of long processes. Whenever the application is loading, processing a file or performing
some time-consuming analyses, the application shows a progress bar indicating the level of progress of
the current task.
Complementarily, a rotating science flask appears accompanied by the word Working... every time
the application is busy, unlike the progress bar that needs to be explicitly called by time-consuming
processes. When R is performing calculations, Shiny adds the class shiny-busy to the html tag;
otherwise, it removes that class. The mentioned flask icon has a JavaScript condition to show or hide
itself depending on that class attribute. When it is active, it can be spotted rotating in the top right of
the page thanks to some CSS styling and the rotating animation provided by FontAwesome10. Since the
rotating animation of the icon is based on CSS3, the animation is not supported by Internet Explorer 9
or older11. One drawback of this approach is that the class shiny-busy is sometimes removed before
the view is completely updated, leaving the user with no indication of progress.
There are other relevant features that will be described in more detail: the modal dialogs to convey
or prompt for information, the data grouping to create and edit groups and perform set operations like
merge and intersect, and the text suggestions to show contextual recommendations on text input fields.
9Notice that Highcharts only provides 10 colours for differentiating series by default which means that assigned colours
repeat when there are more than 10 series as it is shown in figure B.7c
10http://fontawesome.io (last accessed on 15 September 2016)
11http://caniuse.com/#feat=css-animation (last accessed on 21 September 2016)
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5.4.1 Modals
Modals are JavaScript dialogs that obscure the remaining content so that the user focuses on the
displayed message. This is useful for user interactions such as when informing the user, raising warning
and errors or as a data prompt. Modals have a header, body and buttons in the bottom and the body can
contain any HTML content12.
To make the modals visually distinct depending on the information presented, the modal dialogs
were styled with CSS to different styles according to their HTML class attribute: warning, error and info
(figure 5.7).
(a) Default modal (b) Error modal
(c) Warning modal (d) Information modal
Figure 5.7: Modal dialog styled according to the conveyed information.
5.4.2 Data Grouping
Data grouping is contextual. The interface to create and edit groups can only be triggered by a button
near the input fields where groups are needed as it is the case for the principal component and survival
analyses. When the user clicks the mentioned button, a modal dialog opens showing the interface to
create and edit groups (figure 5.8). Created data groups are displayed inside the modal and within an
interactive table.
Each dataset holds their own groups list containing the group name, the row indexes and a repro-
ducible description of the user input (so the user knows exactly what is represented by the group). A big
limitation of this approach is that the datasets must not be modified row-wise unless the group indexes
in the data groups are updated as well to reflect such changes. This was not implemented since datasets’
12http://getbootstrap.com/javascript/#modals (last accessed on 21 September, 2016)
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rows are not supposed to be inserted nor deleted. However, this approach allows for fast set operations
like merge/union and intersect since they only act on row indexes instead of rows of data.
Initially, data groups were positioned in the input tab but its location was confusing given that an
explanation of how the groups would be used for downstream analyses was required. To solve this,
data grouping is now contextual: any input field requiring data groups provides an additional button that
allows to create and edit said groups. The groups.R file contains two functions responsible for showing
the interface and running the logic on the dataset of interest which is passed to the server logic function
as an argument. These dedicated functions make the elements of group selection consistent across the
application and easily placed in any module requiring groups.
Data grouping allows to group rows of a dataset based on columns, row index, subset expression and
regular expression (figure 5.8):
(a) Column grouping (b) Row grouping
(c) Subset grouping (d) Regular expression grouping
Figure 5.8: Data grouping
• If set by columns, the user selects a column from the dataset and groups will be automatically
created based on the unique values of that column. For example, it is possible to group individuals
by tumour stage which would create one group for the individuals at each tumour stage.
• In row index, the user can input the index of the rows of interest separated by commas (e.g. to
indicate a group with the rows 1, 4 to 20 and 36, the user would input 1,4:20,36).
• Subset expression allows to subset a dataset like in R using boolean operators and even running
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functions if desired. The input field shows suggestions for the clinical data attributes to facilitate
writing expressions (see 5.4.3 Text Suggestions).
• Regular expression allows to subset a dataset using regular expressions for a selected column of
that dataset.
Each data group also needs to have a unique name. If the users attempt to set an already used name,
the program will simply add a counter to it. For instance, when creating a group named Tumour when
there is already a group with that name, Tumour (1) will be automatically used instead; then Tumour (2),
Tumour (3), etc.
There are also safeguards in-place to show an alert when the users inputs a wrong expression or tries
to get non-existing data (for example, trying to retrieve the 50th row when there are only 49 rows in the
dataset). As previously mentioned, the group editing interface itself is a modal dialog. When an error
or warning is raised, an alert is shown in the top. Alerts are used instead of modals because stackable
modals are not supported and create a lot of issues.
To allow for set operations, the groups in the data table are selectable and three buttons are available
below the table: merge/union, intersect and remove. These buttons are only enabled if any row is selected.
One of the first implementations of data groups included saving them as attributes of the loaded
datasets. Although this seemed natural at the time, the reactive model of Shiny makes the table in
the Data input section re-render. This is unneeded since the table as a whole does not change, just
one of its attributes. This issue was easily solved by creating variables in the global variable with the
same named of the datasets with the addition of a suffix like Groups. Anyway, since the access and
manipulation of variables inside the global variable is abstracted through accessor and mutator functions,
the implementation can be easily changed as desired.
One additional idea that was not implemented at the time of writing is row grouping13 where rows
of a dataset are displayed and sorted by group. This way, the user could visually browse the elements of
created groups.
5.4.3 Text Suggestions
Text suggestions are provided in a dropdown menu in certain fields to help the user during text
completion. Such completions are useful when the user is writing a dataset column name, for instance.
In this case, the text suggestions can present to the user some suggestions to complete the column name
from all column names available.
To make this more useful, the text completion’s dropdown menu from the JavaScript library jquery-
textcomplete was used with the fuzzy string matching from the JavaScript library fuzzy.js. Fuzzy string
matching (more formally known as approximate string matching) scores the matches between two strings
according to their edit distance. When the user starts typing in a field that supports text suggestions, each
keystroke will show the highest-scored matches. The user can refine the suggestions by continuing typ-
ing. Selectize input elements in this application also support search by default thanks to selectize.js that
13https://datatables.net/examples/advanced_init/row_grouping.html (last accessed on 21
September 2016)
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comes with Shiny, although its engine only allows searching using exact matching by default. How-
ever, its API allows to use another function to give the scores. In the future, the search function may be
replaced by the one from fuzzy.js for consistency and for the improved results provided by this library.
5.4.4 Global Settings
Figure 5.9: Text suggestions for clinical data at-
tributes in the data groups modal.
There are settings to tweak the number of
cores, numeric precision and significant digits
used throughout the application using slider in-
puts. Since the reactive model of Shiny would
trigger analyses to be redone with these values,
it is best if the caller function does not take a re-
active dependency whenever these values change
to avoid performing potentially expensive calcu-
lations without the user’s consent.
The slider for the number of cores to use de-
faults to 1 and allows to choose up to the number
of available cores. Currently, there is no paral-
lelisation performed in the app, so this was devel-
oped for future use. However, there were attempts
at parallelisation during the project. For instance,
the statistical analyses for differential splicing were originally planned to be parallelised but running
them in a Shiny session greatly impacts the computer’s performance, even though the same commands
work successfully when running directly in the R console. This is intended to be further studied in the
future.
5.5 Case Study
To better illustrate the program’s functionality, the following case study is provided as an example
on how to analyse alternative splicing events from samples of patients with adrenocortical carcinoma.
Assuming the program is already installed, the user is required to open an R console, load the pro-
gram using library(psichomics) and start the visual interface with psichomics(). These
instructions are also available in the user tutorial. After the visual interface loads in the default browser,
a welcome message is shown with instructions on how to load data, quantify splicing and filter statisti-
cally significant alternative splicing events (figure B.1).
To load data from Firehose, the user clicks in the Load TCGA/Firehose Data panel, selects the tumour
type, sample date and data type (e.g. clinical data and junction quantification) and clicks on the Load
data button (see figure 5.10). If the required data is not present in the given folder, a modal will appear
informing the user that the archives are now being downloaded and that the user should click on the
Load data button once the downloads have finished. This allows the program to automatically extract
the content of the downloaded archives and organise the files within before loading the files.
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Figure 5.10: Options available to load
data from Firehose.
The loaded datasets are presented to the user (figure
B.2). Each dataset has its own tab named after itself which
shows a description of the dataset, a download button14 and
an input where the user can select the visible columns. The
datasets themselves are shown in interactive jQuery-based
tables provided by the package DT, which allows the user to
filter, sort and search the dataset [53].
Datasets like clinical data contain a large amount of in-
formation to render in a table. While rows are divided in
pages to mitigate performance issues, a large amount of
columns are slowly rendered on-screen. To avoid this issue,
only pre-selected columns defined for a specific file format
are rendered (read subsection 5.2.3: Dataset Loading).
Alternative splicing may be quantified by clicking on
the Quantify alternative splicing events panel and selecting
the junction quantification and alternative splicing annota-
tion (see section 3.3: Alternative Splicing Quantification).
The alternative splicing quantification is shown and is down-
loadable as any other loaded dataset.
Principal component analysis can be performed on the
alternative splicing quantification to compare groups of samples. For instance, samples may be grouped
by tumour stages. Tumour stages 1 and 2 seem to differ from stages 3 and 4 in samples from patients
with adrenocortical carcinoma (figure 5.11).
Figure 5.11: Plot of a principal component analysis
of the alternative splicing quantification for sam-
ples of patients with adrenocortical carcinoma.
As there seems to be a difference between the mentioned groups, they were used for differential
splicing analysis, using the available median- and variance-based statistical tests (read subsection 3.4.3:
Differential Splicing Analysis). The output of differential splicing analysis is a sortable and filtrable
table containing the statistical results for each alternative splicing event (figure B.4). To select statistical
14Although datasets can be loaded from the user’s files, there are some that can be created from the input available. These
datasets benefit more from the download button, which is kept in all datasets for consistency.
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significant events, the p-values of the Wilcoxon rank sum, Kruskal-Wallis rank sum and Levene’s tests
were filtered to below 0.05 and the minimum number of samples per group was set to 20 samples.
To study the impact of alternative splicing events on prognosis, survival data can be incorporated.
Kaplan-Meier curves can be plotted for groups of patients separated by the PSI that maximizes the
significance of their difference in survival (i.e. minimizes the p-value of the difference tests in survival
between individuals with PSI below and above that threshold). Given that calculating the optimal splicing
quantification cut-off can be a slow process, survival analysis is only performed for the 10 events shown
on-screen in the differential splicing analysis table by default.
Figure 5.12: Survival curves for a cut-off
of 99% of exon inclusion for the splic-
ing event SE 17 + 48624646 48625026
48625128 48625644 SPATA20.
One interesting alternative splicing event is a skipped
exon with the identifier SE 17 + 48624646 48625026
48625128 48625644 SPATA20. Its survival curve shows the
minimal log-rank optimal p-value of 0.0197 (which can be
considered significant) and separates 34 (with PSI values be-
low 0.89) from 19 patients (with PSI values higher or equal
to 0.89). By clicking the identifier of the event above the sur-
vival curves, the user is taken to the survival analysis page
where the threshold used to calculate survival difference is
modifiable, among other options (figure B.6).
We may hypothesise that the promotion of isoforms
including the exon of the SE 17 + 48624646 48625026
48625128 48625644 SPATA20 event in patients with adreno-
cortical carcinoma may lead to a smaller lifespan, as the 5-
year survival rate (i.e. the number of patients alive after 5 years) is 41% for patients whose samples
measured exon inclusion levels of 89% or higher versus 68% for the remaining patients.
Finally, the associated gene, transcript and protein annotation is also available to explore the isoforms
and respective proteins that may be affected by the alternative splicing event of interest (figure B.7). This
section of the program also includes relevant literature and interestingly, although the gene SPATA20 is
not reported to be associated to adrenocortical carcinoma, it is a biomarker of bile duct cancer [107].
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Testing
6.1 Unit and Continuous Testing
Unit tests are automated and reproducible executions that validate if a unit of code returns an expected
value, warning the developer if any existing functionality was broken after changing the code [98]. In R,
unit testing can be incorporated using the R package testthat [45]. Each test file comprises an arbitrary
unit of code which can range from testing a single function to a collection of related functions [45].
Similarly, CI automatically builds and tests projects on every change to a repository to ensure the
program is still working after each modification [108]. One exemplary tool is Travis-CI, a remotely
hosted CI that works exclusively with GitHub1. Travis-CI supports a lot of languages including R.
Travis-CI was added to the project to check if the package passes most requirements of Bioconductor
in a Linux virtual machine, making it easy to know when something breaks. It tests against CRAN and
Bioconductor running the commands R CMD build and R CMD check, which need to be passed
with no errors or warnings for the package to be accepted in Bioconductor. The command R CMD
BiocCheck must also be tested afterwards but it is not part of Travis-CI.
Another CI service used is AppVeyor. Similar to Travis-CI, AppVeyor builds and tests the package
in a Windows virtual machine and works as a complement of Travis-CI.
Before Travis-CI finishes running, it asks CodeCov to test the code coverage of the project. This
allows to know the percentage of lines in the code covered by unit tests. Unfortunately, functions with
objects from Shiny are not testable. An obvious workaround is to create normal functions that receive
Shiny objects as arguments.
6.2 Usability Testing
Usability testing evaluates the interface of a program and its quality by identifying design issues.
Improving the problems encountered between different test sessions also allows to check if the potential
fixes resolved pending issues. Ultimately, usability testing may improve user satisfaction [109, 110].
The laboratory usability testing is a common type of usability testing where typical tests are per-
formed by testers following a detailed session script in a controlled environment to identify interface
design issues such as the number, type and severity of errors [111].
1https://travis-ci.com (last accessed on 20 September 2016)
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Another common type of usability testing is known as condensed contextual inquiry where the par-
ticipants are observed in their workplace or home while performing the activities without a strict guide,
taking much more time than other types of usability testing [111]. However, it allows to gather more data
by maintaining an ongoing dialogue with the test participants without influencing their responses.
The laboratory testing can also be conducted in the environment and computers of the participants
in a hybrid approach called field usability testing [111], where test subjects are asked to perform higher-
level tasks and the interaction may be less scripted.
After discussing the nature of the tests with my advisors, we agreed that the usability test script
should be divided into two parts: the first is a rigorous and detailed script with defined tasks, while the
second part is more flexible with only a higher-level task in order to allow test subjects to discuss more
freely what they think of the program’s interface and other attributes (read section C.1: Script).
The selected test participants are 6 members of the Computational Biology Lab from Instituto de
Medicina Molecular and they represent the target audience: users with an expertise on the domain knowl-
edge (alternative splicing quantification and analysis). The downside of selecting these participants is
their familiarity with the project.
The tests were performed in the machine server used by the Computational Biology lab with which
all members are familiar and located in the workplace of the group. All test sessions shared the same
script that encouraged thinking aloud. Interaction with the test participants was kept to a minimum during
task completion, although the last question promotes interactivity with the test subjects. In concordance
with previous studies [109–111], the following metrics were measured while performing the tests:
• Time to complete a task (in seconds)
• Number of usability problems encountered for each task (design issues)
• Comments made while performing the activities
• Opinion regarding the completed task
• Satisfaction regarding the interface used to complete the task based on a Likert-scale (not satisfied,
satisfied, good, very good and excellent) [110]
Note that all measurements were recorded by a single person, which made timing the activities (a
task suggested to be performed by a log-keeper [110]) less accurate. Also, for the same reason, not all
tasks were timed.
After each test, the program was improved to tackle some of the issues encountered by the tester.
Thus, each test underwent a different version of the program, aiming to correct some of the previous
tester’s complaints and implement their suggestions2.
One of the tasks asked to test participants was to describe the program functionality from the wel-
come message available. The answers were pretty similar: the program loads, quantifies and analyses
transcriptomic data from TCGA or from files in the computer. The aim of the program seems to be clear
by reading the welcome message.
There were around 45 distinct design issues noted by the test participants of which 25 (56%) were
solved (see figure C.1). One glaring issue of the program was that the users spent a lot of time (up to 6
2The change log between the different versions of the program used in usability tests are available at https://github.
com/nuno-agostinho/psichomics/releases.
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minutes) looking for the survival analyses. Although users understood they should click on the Analyses
tab, they did not notice the select menu where they could change the current analysis. To decrease time
spent here, a dropdown containing a list of analyses is now accessible by simply clicking on the Analyses
tab. Data grouping was also confusing and two testers took about 7 minutes to understand how it worked.
This was improved by changing the interface and adding contextual clues (disable group selection when
no group is available, animate button to create groups when user clicks on a disabled group selection
input, etc).
The satisfaction for the different interfaces had very good/excellent scores on average for each task
(figure 6.1). The worst score is an average of 4 and corresponds to the survival analysis. One of the
reasons for the sub-optimal score may be the testers’ lack of experience with the interface for data
grouping. Besides, some of the test participants are not experienced in performing survival analysis
either.
Figure 6.1: Percentage of satisfaction of all test participants based on a Likert scale for the different
interfaces available in the program.
The test participants were constantly suggesting enhancements as well, including: add comparison
between transcripts and proteins, link protein domains to respective UniProt page, rewrite messages to
be more precise, etc. Some of these suggestions were implemented, while others suggestions are being
considered.
Usability testing was conducted in a late stage of the program development. Although the members
of the Computational Biology group were present while developing the program, there is a striking
difference between the program before and after the test sessions, as already mentioned above regarding
some of the implemented improvements.
Finally, to further improve usability, external colleagues with expertise in analysing alternative splic-
ing were asked to examine and give feedback on the program by following the steps of a user tutorial
regarding the visual interface and their feedback is expected soon.
6.3 Benchmarking
The most time-consuming steps of the program were worked on to take the least possible amount
of time. These steps comprise data loading, alternative splicing quantification and differential splicing
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analysis.
Figure 6.2: Processes’ running time average over 10 runs for multiple
tumour types. The tests were performed using the visual interface.
Common tumour types
from TCGA were selected
for this benchmark, includ-
ing the liver hepatocellular
carcinoma data of 377 pa-
tients (a close number to the
average and median number
of available patients per tu-
mour type) and the breast
invasive carcinoma data of
1097 patients (the tumour
type data containing the most patients in TCGA).
The time to load data, quantify alternative splicing and analyse differential splicing of all splicing
events is largely dependent on the number of samples available. The performance of differential splicing
analysis is also dependent on the number of groups that are compared and the type and number of
statistical analyses performed.
The visual interface adds an overhead to the performance. To account for the worst-case scenario,
the benchmarking was performed in the visual interface.
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Deployment
The project is publicly hosted online in GitHub (https://github.com/nuno-agostinho/
psichomics) and is currently under review to be accepted in Bioconductor [17]. These two modes of
distribution allow the program to be installed and locally run on the user’s computer. However, it would
be more appropriate for the application to be remotely accessible through a web browser. Therefore, there
are plans to deploy the application in a web server following the ongoing upgrade in the computational
infrastructure available at Instituto de Medicina Molecular.
Nevertheless, the application still needs modifications before being hosted in a web server. At the
moment, file loading is based on looking for valid files in a given folder. Unfortunately, this can only be
done by R in a local installation because HTML5 does not allow to prompt for folders (only for one or
multiple files)1. A workaround would be to ask the user to zip the folder of interest, although that idea
departs from good usability.
As the tool is currently available in GitHub, the master and the dev branches are used to distribute
a stable and a development version of the package, respectively. Whenever the changes accumulated in
the development branch are satisfactory and pass the CI tools without issues, they are merged with the
stable branch. A new version release may even be accompanied with a change log.
7.1 License
An open-source program requires a suitable license. Licenses can be permissive enough to allow
developers to modify and distribute the program and use it commercially and privately, with the condition
that a copy of the license and copyright notice are included in the code (e.g. MIT license and Apache
License 2.0). There are also copyleft licenses such as Mozilla Public License 2.0 and derivatives of the
GNU GPLv3 licenses that demand the use of the original license in any work derivatives and to disclose
the source code (depending on the license, the source code to be disclosed may be the modifications
performed to the GPL-licensed work or even the full source code of the program).
The current public version of the software holds an MIT license and all original or modified code
from external sources is compliant with the chosen license, including the external JavaScript and CSS
libraries distributed with the program.
1https://developer.mozilla.org/en-US/docs/Web/HTML/Element/input (last accessed on 20
September 2016)
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Conclusions
With the increasing amount and resolution of biological data available, we are able to study biological
processes with more precision than ever before [1]. There is a great amount of data available online
in public repositories that can be freely used to analyse processes of interest, such as the data from
TCGA [10]. These data can be used to study biological process such as alternative splicing, which is a
major contributor to protein diversity in many organisms [2,3]. Reportedly, the deregulation of alternative
splicing may foster the progression of cancer and other diseases [4–8].
PSIchomics is presented as a tool to quantify, analyse and visualise alternative splicing in tumour and
normal samples from TCGA with the assistance of interactive visualisations and analyses, including sur-
vival, principal component and differential splicing analysis. It tries to fill the gap from other analytical
tools currently used by:
• Quantifying alternative splicing from already processed data (read section 3.3: Alternative Splicing
Quantification)
• Incorporating available clinical information.
• Performing analysis of variance.
• Possessing an easy-to-use interface (read section 6.2: Usability Testing).
To accommodate the rapidly changing field of bioinformatics, the program’s architecture was de-
signed around modifiability to promote modularity, extensibility, unit testing and collaboration with de-
velopers and biologists interested in analysing alternative splicing (read section 4.4: Architecture). Tem-
plates and examples are provided in the program to allow developers to create and extend the program
with support for new databases and file formats, new analyses and visualisations or new data processing
tools.
A full-fledged analysis (including clinical information and junction quantification data loading, al-
ternative splicing quantification and differential splicing analysis) can take less than 10 minutes for more
than 1000 patients (see section 6.3: Benchmarking). As exemplified in section 5.5: Case Study, users
of this program can find alternative splicing signatures that are specific of a tumour type, tumour stage
or other clinical attributes. These splicing events can then be further studied to validate them as putative
prognostic factors and even therapeutic targets.
The application is publicly available in GitHub (http://github.com/nuno-agostinho/
psichomics) and is under review in Bioconductor to be released by Mid-October 2016.
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8.1 Future Work
GitHub has a feature to list software bugs, suggestions and improvements. That feature (called
GitHub issues) has been used to list all future improvements and questions, some of which are mentioned
in this document1, such as the implementation of beta regression analysis to study the distribution of PSI
values (read subsection 3.4.3: Differential Splicing Analysis).
The performance of the program can also be improved. For instance, sections of time-consuming
functions could be converted to C++ for performance improvements2 and/or parallelised (specially when
performing multiple independent calculations, such as in the case of differential analyses).
Although the package quantifies and analyses alternative splicing data using TCGA data, it could
have a broader appeal by accepting data from other databases. For example, a few members of the
Computation Biology lab at Instituto de Medicina Molecular analyse alternative splicing using data from
neurodegenerative diseases and normal tissue. Consequently, an ambitious goal of the application would
be to study alternative splicing changes outside of the context of cancer by including, for instance, GTEx
support. Unfortunately, data from this project is currently unaccessible given that they do not share a
public API.
We are also awaiting the upgrade of the computer infrastructure at Instituto de Medicina Molecular
to deploy the program in a web server. Allowing users to remotely access the program through a web
browser has two major advantages: it avoids the installation of all the associated software and allows to
always use the latest version of the program available.
1https://github.com/nuno-agostinho/psichomics/issues
2Note that third-party C functions are already employed in some cases, such as when loading files.
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Source code
A.1 Format of the Clinical Information
firehoseClinicalFormat <- function() {
list(
tablename = "Clinical data",
filename = "clin.merged.txt",
description = "Clinical data of the patients",
dataType = "Clinical data", # General data category
# Transpose the data? This is the first step before
# parsing the information. After transposition, a row
# of the current data equals a column of the original.
transpose = TRUE,
# Format checker information
rowCheck = TRUE, # Check format by row or column
checkIndex = 1, # Row/column index to check the format
# File string to check
check = c("admin.batch_number", "admin.bcr",
"admin.day_of_dcc_upload",
"admin.disease_code", "admin.file_uuid",
"admin.month_of_dcc_upload"),
# Parsing information
delim = "\t", # Delimiter used to separate fields
colNames = 1, # Row to use for column names
rowNames = "patient.bcr_patient_barcode", # Column for row names
ignoreCols = NULL, # Columns to ignore
ignoreRows = 1:2, # Rows to ignore
commentChar = NULL, # Comment symbol; comments are ignored
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# Other options
unique = FALSE, # Remove duplicated rows
# Default columns to show (NULL to show all)
show = c("patient.stage_event.pathologic_stage_tumor_stage",
"patient.vital_status", "patient.race",
"patient.days_to_death",
"patient.days_to_last_followup",
"patient.radiation_therapy", "patient.gender",
"patient.clinical_cqcf.histological_type",
"patient.ethnicity", "patient.race_list.race"),
process = function(data) {
# Add suffix to identify column detailing tumour stages
col <- grep("stage.*pathologic_stage", colnames(data))
colnames(data)[col] <- paste0(colnames(data)[col],
"_tumor_stage")
return(data)
}
)
}
attr(firehoseClinicalFormat, "loader") <- "formats"
A.2 Template for an Analysis File
#’ User interface of template
#’ @param id Character: namespace identifier
#’
#’ @importFrom shiny NS tagList sidebarPanel mainPanel sliderInput
#’ actionButton uiOutput
#’ @importFrom highcharter highchartOutput
#’
#’ @return HTML elements for the interface of the template
templateUI <- function(id) {
ns <- NS(id) # Identifier
tagList(
sidebarPanel( # Sidebar interface
sliderInput(inputId=ns("num"), label="Number of samples",
min=1, max=20, value=4),
actionButton(inputId=ns("submit"), label="Plot")),
mainPanel( # Main interface
uiOutput(outputId=ns("text")),
highchartOutput(outputId=ns("plot"))))
}
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#’ Server logic of template
#’
#’ @param input Shiny input
#’ @param output Shiny output
#’ @param session Shiny session
#’
#’ @importFrom shiny renderUI observeEvent isolate tagList tags
#’ @importFrom highcharter renderHighchart
templateServer <- function(input, output, session) {
# Wait for user to press the button
observeEvent(input$submit, {
# Break reactive dependence
num <- isolate(input$num)
# Retrieve random samples
sample <- sort( sample(100, size=num, replace=TRUE) )
# Print samples
output$text <- renderUI(tagList(tags$b("Samples:"),
paste(sample, collapse=" ")))
# Plot frequency
output$plot <- renderHighchart( hchart(sample) )
})
}
attr(templateUI, "loader") <- "analysis"
attr(templateUI, "name") <- "Template"
attr(templateServer, "loader") <- "analysis"
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Figure B.3: Interface for principal component analysis (PCA). The plot depicts PCA of the alternative
splicing quantification for samples of patients with adrenocortical carcinoma.
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Figure B.5: Interface of differential splicing analysis for one event showing the distribution of alternative
splicing quantification for samples of patients with adrenocortical carcinoma across tumour stages.
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Figure B.6: Survival curves (top) and Cox proportional hazards model fit (bottom) for patients with
adrenocortical carcinoma separated by a PSI cut-off for a given alternative splicing event.
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(a) Gene information including links to external databases and relevant literature.
(b) Static plot of the gene’s transcripts highlighting an alternative splicing (skipped exon) event.
(c) Interactive plot of a selected UniProt protein with some protein features omitted (light gray) and showing a
tooltip for a specific feature.
Figure B.7: Gene, transcripts and protein annotation provided by PubMed Central (a), Ensembl (a and
b) and UniProt (c) for a given gene.
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Usability Testing
C.1 Script
This script was used during the sessions with test participants (see section 6.2: Usability Testing).
C.1.1 Instructions
I will present you a new tool to analyse alternative splicing from tumour transcriptomic data. The tool
allows you to load data from The Cancer Genome Atlas (TCGA) database and to perform exploratory
and survival analyses, as well as differential splicing analysis using non-parametric statistical tests.
This enquiry evaluates the tool’s interface and user interaction to assess a user can easily and quickly
analyse data. I will give you general tasks and pose some questions and let you explore the program to
give me the answers. The time you take to answer will be recorded to compare with other testers, in
order to identify common time-consuming steps.
At any time, you may ask questions regarding the tool, but please understand I will avoid giving you
the answer right away unless you are unable to proceed.
Finally, I would like to stress the importance of thinking aloud. As the tests serve the purpose
of analysing the tool’s intuitiveness and usability, I would like to know your train of thought when
performing the tasks to understand what catches your attention and what may confuse you. I would also
like to know of any suggestions you may have regarding how you complete the tasks.
If you have any further questions, I will be happy to answer them. Else, we may now start the test.
C.1.2 General Questions
1. Is the interface clear and intuitive?
2. How do you describe your satisfaction with the interface regarding the completed tasks: not satis-
fied, satisfied, good, very good or excellent?
C.1.3 Tasks
1 Read and follow the instructions from the GitHub page to start the program.
1.1 Describe the interface. What do you think the software allows you to do?
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2 Load the most recent version of Bladder Urothelial Carcinoma (BLCA) data from TCGA
(both clinical data and junction quantification).
2.1 Is the message that appears clear to you? Why do you click the ”Load data” button twice?1
2.2 How many patients are loaded? How many are female? How many are asian females? How
many patients in total are in stage III of the disease?
3 Analyse survival data.
3.1 Analyse survival data by tumour stage of the disease with time to death as the follow-up time
and death as the event of interest. Perform a Kaplan-Meier plot and fit a Cox proportional
hazards model.
3.1.1 Are there groups with zero survivors? Are the curves’ differences significant?
3.2 Analyse survival data by tumour stage, gender and race. Perform a Kaplan-Meier plot and fit
a Cox proportional hazards model.
3.2.1 Are there groups with zero survivors? Are the curves’ differences significant?
3.3 Is group creation clear? What is the difference between group selection types?
3.4 Try zooming in any point of interest. Try omitting some data series.
4 Analyse differential splicing using all the statistical tests.
4.1 Is the error message ”missing splicing events quantification” clear? Load missing data.2
4.2 Filter the statistical significant events and sort them by variance difference.
4.3 Include survival curves separated by the optimal alternative splicing quantification cut-off of
each event (time to death and death events).
5 Choose a relevant alternative splicing event from the top of the previous table.
5.1 Do all groups share the same distribution of alt. splicing quantification? What is the median
and variance of the primary solid tumour group?
5.2 Using the selected event, plot a Kaplan-Meier that maximises the survival difference for a
given cut-off of the alternative splicing quantification. Is the difference significant?
5.3 Which gene, transcripts and proteins are related to the selected alternative splicing event?
5.4 Check if there’s any evidence of the association of that gene with cancer in the literature.
6 Perform principal component analysis (PCA) on the alternative splicing quantification and
colour by tumour stage.
7 Find relevant alternative splicing events for another type of tumour.
1A modal message appears to inform that the data is being downloaded and the user needs to notify the program when the
download has finished.
2This error message appears if the user did not yet quantify splicing.
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C.2 List of Design Issues Encountered
I1. Problem opening visual guide
I2. Indicate most recent sample
I3. Folder to store data is not clear
I4. Improve text of the downloading data message
I5. Filtering in Data tab is exclusively for data visualising purposes
I6. Suggest unique values when filtering a data column
I7. Misunderstood message that required data is not available
I8. Problem finding number of loaded patients
I9. Download the whole subset of a table
I10. Make it easier to change analyses
I11. Calculate optimal sample size for survival curves to avoid having curves with a small number of
patients
I12. Show number of patients in each survival curve
I13. Tries to write name of groups of interest; does not click in Groups button to create groups
I14. Did not find the column for tumour stages
I15. Tried selecting groups with the mouse (click and drag)
I16. User did not understood groups were available after clicking create group
I17. Tries to create intersecting groups from the group selection instead of using a formula
I18. Formula interface has no instructions
I19. Zooming and series omitting in interactive plots are not intuitive
I20. Not clear how to filter columns
I21. Load junction quantification message not understood
I22. Confused by the uncheckable statistical tests
I23. Rewrite message regarding too many missing values
I24. No indication that alternative splicing quantification is finished
I25. Use clinical groups in differential splicing analysis
I26. Restrict analysis to paired-matched samples
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I27. Manual column filtering of tables is inflexible
I28. Improve column names of the differential splicing analysis table
I29. Does not notice options for survival analyses in differential analysis
I30. Table is redrawn when calculating optimal PSI values to separate survival curves; custom state of
the table is lost
I31. Finds text for PSI cut-off confusing
I32. Not sure how to get to differential analysis per splicing event
I33. Allow to click in density plot to go to differential analysis per splicing event
I34. Testers do not notice event of interest is selected
I35. Confusing when taking user to survival curves after a plot was drawn
I36. Protein selection is not intuitive
I37. Improve display of the transcript names and better highlight the splicing event
I38. No indication of the plots correspond to transcripts
I39. Add relevant PubMed articles
I40. Explain difference between the two group selection boxes in PCA
I41. Add information on value imputation
I42. Create groups based on events or individuals of interest
I43. Inform PCA calculation has finished
I44. Tester does not remember where to separate survival curves by alternative splicing quantification
I45. Message asking to replace data appears even if data is going to be downloaded
C.3 Table of Design Issues by Task and Tester
Task Issue U1 U2 U3 U4 U5 U6
1 I1 Problem
1.1 I2 Try Solved
1.1 I3 Problem Problem Problem Problem
1.1 I4 Problem Try Solved
2.1 I5 Problem
2.1 I6 Problem Problem Problem Solved
2.1 I7 Solved
2.2 I8 Problem
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2.2 I9 Solved
3 I10 Problem Try Problem Problem Solved
3 I11 Problem
3 I12 Solved
3.1 I13 Problem Try Problem Problem Solved
3.1 I14 Problem Problem Problem Try Solved
3.1 I15 Problem Problem Problem
3.1 I16 Try Solved
3.2 I17 Problem Solved
3.2 I18 Solved
3.4 I19 Problem Problem Problem Problem
4 I20 Problem
4.1 I21 Problem Try Solved
4.1 I22 Problem
4.1 I23 Solved
4.1 I24 Solved
4.2 I25 Problem Solved
4.2 I26 Problem
4.2 I27 Problem Problem
4.2 I28 Solved
4.3 I29 Problem
4.3 I30 Problem Problem Problem Problem Problem Solved
4.3 I31 Problem Problem
5.1 I32 Solved
5.1 I33 Problem Solved
5.2 I34 Problem Problem Problem Solved
5.2 I35 Problem Problem Solved
5.2 I36 Problem
5.3 I37 Problem
5.3 I38 Solved
5.3 I39 Problem Solved
6 I40 Try Problem Problem
6 I41 Solved
6 I42 Problem
6 I43 Problem
7 I44 Problem
7 I45 Problem
Table C.1: Design issues by task and tester encountered during usability testing. The list of issues is
available in section C.2: List of Design Issues Encountered. Legend: problem is an issue that was not
solved; try is an issue that was not successfully solved; and solved refers to an issue that was taken care
of. An issue is considered solved unless the next test participants encounter a similar design issue.
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